A cytotoxic evaluation of aflatoxin B1, zearalenone and their epoxide derivatives using human cell lines. by Pillay, Dharmarai.
A CYTOTOXIC EVALUATION OF AFLATOXIN B., 
ZEARALENONE AND THEIR EPOXIDE DERIVATIVES USING 
HUMAN CELL LINES 
BY 
DHARMARAIPILLAY 
Bsc (Hons) Natal 
Submitted in partial fulfilment of the requirements 
for the degree of M.Med Sci 
in the 
Department of Physiology, Faculty of Medicine 
University of Natal, Durban. 
1996 
In memory of my grandmother 
.. 
ABSTRACT 
Since the discovery of mycotoxins in food, the thrust of biochemical and toxicological 
research has been carried out on animals which has proven to be uncoordinated and not 
easily extrapolated to humans. Over the last decade, there have been increasing pressures 
to review and reduce the use of animals in experimental toxicological studies. 
Consequently in this study aflatoxin Bl (AFB1) , zearalenone (Zea) and their epoxide 
derivatives have been evaluated using in vitro assays. The HepG2, A549 and Hela cell 
lines were used for assessing the cytotoxicity, effects on cellular metabolism and sites of 
action of AFBl, Zea and their derivatives. The cytotoxicity of these mycotoxins was 
evaluated using the methylthiazol tetrazolium (MTT) reduction assay. Cells, treated with 
mycotoxins were prepared for transmission electron mlcroscopy (TEM), 
immunocytochemistry (ICC), scanning electron microscopy (SEM), confocal and light 
microscopy. From the cytotoxicity assay it was found that the epoxide derivatives were 
more toxic than the parent toxin when exposed to HepG2 cells with no significant 
differences in toxicity levels in A549 and Hela treated cells. Both epoxide derivatives 
displayed a regression of hepatoma cell proliferation at high doses (251lg/ml) while lower 
concentrations «12.51lg/ml) enhanced cell growth. Microscopy analyses showed distinct 
cellular alterations. When exposed to AFBl (12.51lg/ml) hepatoma cells showed 
prominent ultrastructural alterations such as areas of cytoplasmic lysis and increased 
numbers of secondary lysosomes while cells exposed to Zea (l2.51lg/ml) displayed 
numerous ovoid mitochondria and proliferation of rough endoplasmic reticulum which is 
indicative of enhanced protein synthesis. The presence of label in toxin treated cells is 
suggestive of the effects of these mycotoxins. Such cellular changes may lead to altered 
metabolism and cell function. 
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As life began to evolve, the first macromolecules occurred as complex arrays with 
the basic attributes to life. This was accompanied by environmental factors that 
represented disruptive forces. These forces were not only physical but chemical as well. 
Chemicals existed in the early milieu of life that interacted with these life forms, disrupting 
the delicate balances through which they maintained their integrity ( deBethizy and 
Hayes, 1989). Those life forms that developed protective mechanisms such as cell 
membranes and the ability to store energy were able to survive. These early life forms 
manufactured molecules capable of reacting with environmental chemicals and thus 
decreased their biological activity (deBethizy and Hayes, 1989). The next step in the 
evolution of protective mechanisms may have been the development of macromolecular 
catalysis to chemically alter disruptive chemicals. Today cellular mechanisms exist for 
metabolising the thousands of naturally occurring and synthetic toxins to which cells and 
cellular systems are exposed. Certainly not all mechanisms help to protect the living 
system and therefore toxicology has become an integral part of understanding the cellular 
environment. 
1.2 The science of toxicology 
The science of toxicology is a unification of a number of scientific disciplines 
(biochemistry, pharmacology and pathology) directed towards a common goal of 
identification, quantification and mechanistic explanation of adverse effects between a 
chemical substance and a living organism or biological system. 
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A major concern of individuals and societies has been and is the attainment of 
sufficient food to provide a healthful and productive life. Food is a complex chemical 
mixture containing nutrients and a vast diversity of other substances. Because food is of a 
biologic origin, it contains molecules important to the survival of the particular plant or 
animal species from which it was obtained. These molecules are xenobiotic to human 
biochemistry. They are more likely to produce adverse effects in humans. This study 
focuses on fQod-Q.9fQ.e t<?~i.E~.!1!~ that are present as contaminants, secondary to microbial 
invasion of foods. These toxicants are referred to as mycotoxins and are produced in food 
ingredients that cause adverse biological effects when consumed in sufficient quantities. 
Many adverse human health effects have been linked to the dietary contamination 
of foods with mycotoxins. Despite intensive research on mycotoxins the mode of their 
toxic action on humans is largely unknown. Currently there is great interest in the effects 
of mycotoxins on humans , in order to assess the dangers and likely results of populations 
being exposed to dietary mycotoxins in both first and third world countries. 
1.3 Objectives 
The three mycotoXins selected for investigation in this study were aflatoxin B 1 
(AFB 1), aflatoxin B2 (AFB2) and zearalenone (Zea). The aflatoxins which are the most 
prominent mycotoxins in South Mrica have been widely studied with AFBl being the 
focus of interest. Its carcinogenic properties are reputed to be related to its ability to form 
an epoxide in the liver. Consequently in this study the cytotoxic effects and mechanisms of 
action of these mycotoxins of importance in the South African context have been . 
investigated using three human cell lines; namely, HepG2 (liver carcinoma cells); A549 




2.1 MYCOTOXINS AND MYCOTOXICOSES 
2.1.1 Introduction 
"Wailing and writhing men collapsed in the street; others fell over and foamed 
in epileptic fits whilst some vomited and showed signs of insanity. Many of them 
shouted, " Fire! I'm burning". It was an invisible fire that separated the flesh from 
the bones and consumed it. Men, women and children died in unbearable agonising 
pain. " 
These were the words used by a tenth century chronicler to describe a disease which 
affected many parts of Europe in 943 AD (Coker, 1995). The disease became known 
as "St Anthony's fire" because of the burning sensation experienced by the victims, 
many of whom visited the shrine of St Anthony in France in the hope of being cured 
(Coker, 1995). "St Anthony's fire" was caused by the consumption of rye 
contaminated with ergot alkaloids, compounds produced by moulds as secondary 
metabolites and referred to as mycotoxins (Coker, 1995). 
Living organisms are continuously being exposed to an increasing number and 
variety of potentially harmful toxic compounds. The exposure of humans to fungal 
metabolites has become a major concern since the discovery of atlatoxins, a fungal 
metabolite produced by Aspergillus flavus and A. parasiticus, common and widely 
distributed food spoilage fungi (Groopman et al. , 1988). The discovery of the 
atlatoxin metabolites led to more intensive studies of mycotoxins and to the 
identification of a variety of compounds linked with adverse human health effects. 
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2.1.2 Mycotoxins 
Mycotoxins are secondary metabolites which are products of metabolism 
whose formation is induced by the abnormal stress which results from limitations to 
normal growth patterns in the microbial cell (Weinberg, 1971). Several hypotheses 
have been postulated to explain the production of secondary metabolites in micro-
organisms. The suggestion that they have no function and are produced as a result of 
the breakdown in the regulation of the cells metabolism is considered unlikely in view 
of the intense pressure of natural selection which can be expected to occur. It has also 
been postulated that the specific products of secondary metabolism are not important 
but the process of secondary metabolism is of selective advantage to the organism. It is 
considered to provide a mechanism by which excess intermediates can be metabolised 
during adverse growth conditions. Such a mechanism would serve to maintain the cell 
in a functional state during conditions which prevented growth (Bu'lock, 1975). These 
adverse growth conditions occur when some environmental factor (nutrient availability, 
temperature and water activity) becomes limiting (Smith and Moss, 1985). 
2.1.3 Conditions promoting fungal growth 
Fungi are a major cause of deterioration and spoilage in stored crops. Spoilage 
fungi attack food and feed crops after harvest whenever environmental conditions 
become favourable for their proliferation (Smith & Moss, 1985). Moisture content of 
the seed and grain, its viability and physical state, ambient temperature, length of 
storage and activity of stored product insects are the main factors that determine both 
the initiation and extent of mould growth (Smith & Moss, 1985). The sources of 
contamination of any food commodity varies. Often the origin of fungi in food is the 
very buildings used for storage and ripening. The moulds may proliferate on the walls, 
ceilings and floors of these buildings. Spoilage of a product can manifest itself after 
several months of storage. Storage facilities include underground pits and storage bins. 
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The factors affecting fungal growth include; substrate composition, 
temperature, water availability and pH. Substrates differ in their ability to support 
fungal growth due to differences in their physical and chemical characteristics (Lebars 
1982, as cited by Gqaleni, 1996). Physical characteristics include water activity, 
oxygen availability and surface area; while chemical characteristics include 
carbohydrates, fat and protein content, trace elements and amino acid composition. 
Moisture determines whether microbes can colonise a substrate or not (Gqaleni, 1996). 
It has been suggested that the most important factor in growth and aflatoxin production 
is the moisture surrounding the natural substrate (Smith and Moss, 1985). Although 
pH is usually easy to determine it is more difficult to control since the growth of fungi 
change the pH of the substrate (Gqaleni, 1996). Most fungi grow over a wide range of 
pH. 
The proliferation of moulds on food may simply result in it having an 
unacceptable appearance. Mouldy foods are consumed throughout the world during 
times of famine, as a matter of taste and through ignorance of the adverse health 
effects. Modern toxicology has evolved rapidly during the past hundred years. The 
exponential growth of this discipline can be traced to the world war two era which 
marked the increase in the production of drugs, pesticides and chemicals. The threat of 
mycotoxins to human and animal health has become more important as the demand on 
the available food supply increases. The presence of mycotoxins is potentially the most 
serious quality problem which faces producers, manufacturers and handlers of food . 
The United Nations Food and Agricultural Organisation has estimated that up to 25% 
of the worlds foods are contaminated with mycotoxins (Smith and Moss, 1985). There 
is therefore this urgency to minimise their presence in foods. 
RE. rWm e @ 
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The following diagram illustrates the factors affecting mycotoxin production 
1 2 3 
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Fig 2.1 
Animal products 
Factors affecting the occurrence of mycotoxins in the food chain (Smith 
et aI. , 1994). 
2.1.4 Mycotoxicoses 
Mycotoxicoses has been defined as those illnesses of man and animals caused 
by toxigenic fungi (Moreau, 1970). In most instances toxigenic moulds that grow and 
proliferate on food products diffuse into it which is followed by the ingestion of these 
toxin contaminated foods and subsequent toxin-related diseases in man and animals. 
Mycotoxicoses are often associated with effects on the liver and kidney, and thus the 
fungal toxins are frequently hepatotoxic and nephrotoxic. A mycotoxicosis is essentially 
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characterised by being neither contagious nor infectious but by the fact that toxins are 
responsible. There exists three forms of mycotoxicoses; acute primary mycotoxicoses, 
chronic primary mycotoxicoses and secondary mycotoxin diseases. 
Acute primary mycotoxicoses 
Animals have been found to show marked signs of disease and death. Observed 
acute disease syndromes include hepatitis, haemorrhage and nephritis. Fortunately, 
natural contamination levels of mycotoxins are not high to allow for acute primary 
mycotoxicoses but instead promotes chronic primary mycotoxicoses (Smith et 
aI., 1994). Humans would normally avoid foods that are visually contaminated by 
moulds and thus human health problems resulting from exposure to acutely toxic levels 
are relatively rare (Smith et aI. , 1994). 
Chronic primary mycotoxicoses 
There are no dearly defined macroscopic changes in the infected individual. 
Symptoms would appear in groups of animals as reduced productivity in the form of 
reduced egg production and reproductive efficiency. 
Secondary mycotoxin disease 
The biological effects of mycotoxins are chronic due to their wide variety of 
chemical structures. Some of these effects would be mutagenic, oestrogenic, 
carcinogenic and embryotoxic. This may also be accompanied by suppressed 
Immunoresponses. Mycotoxins may enter the human dietary system by direct or 
indirect contamination of foods. Direct contamination occurs when the food becomes 
infected with a toxigenic fungus and subsequently produces the toxin. On the other 
hand indirect contamination occurs when an ingredient of a process is already 
contaminated with a toxin-producing fungus and while the fungus may be removed 
during processing, the mycotoxins still remain in the final product. The human body 
copes with these toxicants via a variety of metabolic processes essential in maintaining 
cell integrity. 
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2.1.5 Absorption, distribution and excretion of toxicants 
The toxicity of any substance depends on the dose. Ultimately it is not the dose 
but the concentration of the toxicant at the site(s) of action that determines 
cytotoxicity. The same dose of two or more chemicals may lead to vastly different 
concentrations in a particular target organ of toxicity. This differential pattern may be 
due to differences in the disposition (absorption, distribution, biotransformation and 
excretion) of the xenobiotics. The various factors affecting disposition are depicted in 












Routes of absorption, distribution and excretion of toxicants in the body 
(Klaasen and Rozman, 1991). 
Any or all of these factors may have a minor or major effect on the 
concentration and thus the toxicity of a chemical in a target organ. If the amount of 
chemical absorbed is small then it may never reach sufficiently high concentrations at a 
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potential site of action to cause toxicity or the biotransformation may result in the 
production of a less or more toxic metabolite (Klaasen and Rozman, 1991). All of 
these processes are interrelated. The rate of excretion of a chemical may depend on its 
distribution and or biotransformation. If a chemical is distributed to and stored in fat, its 
elimination is likely to be slow. 
Absorption 
Absorption occurs when toxicants cross body membranes and enter the blood 
stream. The main sites of absorption are the gastrointestinal tract (GIT), lungs and the 
skin. The GIT is one of the most important sites where toxins are absorbed. Many 
environmental toxicants are absorbed together with food from the GIT. This tract is 
viewed as a tube traversing the body although in the body, its contents are considered 
exterior to it. The mammalian GIT has specialised transport systems (carrier-mediated) 
for the absorption of nutrients and electrolytes. After entering the blood, a toxicant is 
available for distribution. 
Distribution 
The rate of distribution to organs or tissues is primarily determined by blood 
flow and the rate of diffusion out of the capillary bed to the cells of the target organ 
(Klaasen and Rozman, 1991). The penetration of toxicants into the cells occurs by 
passive diffusion or special transport processes. Some toxicants accumulate in certain 
parts of the body due to protein binding, active transport or high solubility in fat. 
Several plasma proteins bind xenobiotics and some physiological constituents in the 
body. Albumin, the most abundant plasma protein, binds a large number of different 
compounds. Albumin serves as a depot and transport protein for both endogenous and 
exogenous compounds. Transferrin, a Bl -globulin is important for the transport of 
iron in the body. The a and B lipoproteins are important for the transport of lipid 
soluble compounds such as vitamins and steroid hormones (Klaasen and Rozman, 
1991). Liver and kidney have a high capacity to bind a multitude of chemicals. Many 
organic compounds are highly lipophilic and thus rapidly penetrate cell membranes and 
concentrate in body fat. The binding of compounds to plasma proteins, particularly 
albumin, is of special importance to toxicologists because severe toxic reactions can 
arise if a toxicant is displaced from plasma proteins by another agent thus increasing the 
free fraction of the former in the plasma (Klaasen and Rozman, 1991). 
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Excretion 
The kidney is probably the most important organ for the excretion of 
xenobiotics. Many of the xenobiotics have to be biotransformed into more water 
-soluble products before they can be excreted into the urine. Other routes of elimination 
are via the faeces and the lungs. 
Conclusion 
When the rate of absorption exceeds the rate of elimination, toxic compounds 
may accumulate to a critical concentration at a certain target site and toxicity may 
result. Many . chemicals have very low inherent toxic ,effects and need to be activated by 
biotransformation into toxic metabolites to elicit its effects as seen in figure 2.3 
(Klaasen and Rozman, 1991). On the other hand a very potent toxicant may be 
detoxified rapidly by biotransformation. Thus a toxic response produced by a 
xenobiotic is critically influenced by the rate of absorption, distribution, 
biotransformation and excretion. 
Chemical bsorption ...,.:::::----------------.rharmacological effect 
nontoxic 
~ 










Schematic representation of the disposition and toxic effects produced 
by chemicals (Klaasen and Rozmann, 1991). 
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2.1.6 Biotransformation of toxicants 
2.1.6.1 Introduction 
The rate at which compounds are eliminated from the body, via the kidney 
depends on their water solubility. Biotransformation is the sum of the biochemical 
processes involved in converting lipophilic compounds to more hydrophilic metabolites 
(Sipes and Gandolfi, 1991). The metabolites produced are more hydrophilic than the 
parent compound. This increased water solubility reduces the ability of the metabolite 
to partition into biological membranes and therefore hinders this distribution to the 
various tissues and ultimately promotes the excretion of the chemicals. Since the liver is 
the most biochemically active organ in the metabolism of xenobiotics, the detoxification 
of chemical substances is frequently assessed using liver derived systems. Ultimately, 
the sensitivity of a biological system to toxic insult is defined and characterised by the 
presence of critical molecular targets. Of these macromolecules, proteins possess highly 
specific functional characteristics. In the case of nucleic acids, DNA is a critical 
toxicological target, through covalent binding of reactive chemical toxicants because of 
the known associations between chemical modification of DNA and mutagenicity and 
carcinogenicity (Sipes and Gandolfi, 1991). The biotransformation of foreign 
compounds within the liver is accomplished by its biphasic character involving several 
enzyme systems. 
2.1.6.2 Phase 1 and phase 2 biotransformation 
Various enzymes can biotransform lipid-soluble xenobiotics into water soluble 
compounds via phase 1 and phase 2 enzyme reactions. The former involves oxidation, 
reduction and hydrolysis whilst the latter consists of conjugation or synthetic reactions 
where the foreign compound or phase I-derived metabolite is covalently linked to an 
endogenous molecule (e.g. glucuronic acid) producing a conjugate which is more water 
soluble (Sipes and Gandolfi, 1991). These conjugating moieties are added to the 
endogenous products to promote their secretion. These reactions are biosynthetic and 
require energy which are achieved by activating the cofactors or the substrates to high 
energy intermediates (Sipes and Gandolfi, 1991). Phase 1 reactions allow for the 
addition or removal of functional groups (e.g. -OH, -SH, NH2, -COOH) (Sipes and 
Gandolfi, 1991). These functional groups allow the compound to undergo phase 2 
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reactions. The relationship between phase 1 and phase 2 reactions is illustrated in figure 
2.4. Volatile organic compounds may be eliminated via the lungs with no 
biotransformation. Those compounds with functional groups may be conjugated 
directly while others undergo phase 1 reactions before conjugation. Biotransformation 
is complex and integrated. 
Tissue accumulation Expose/add Phase1 product 
functional grOUPS~ ~ 
Elimination 
Fig 2.4 
No Biotransformation Xenobiotic Elimination 
/ 
Phase 11 product 
The integration of phase 1 and phase 2 biotransformation reactions 
(Sipes and Gandolfi, 1991). 
The enzyme systems which catalyse the biotransformation of foreign 
compounds are localised primarily in the liver (Sipes and Gandolfi, 1991). The liver 
receives all the blood that has perfused the splanchnic area which contains nutrients and 
foreign substances, and thus it has developed the capacity to extract the nutrients and 
xenobiotic compounds readily from the blood and to chemically modify many of these 
substances before they are stored, secreted into bile or released into circulation (Sipes 
and Gandolfi, 1991). The phase 1 enzymes are located primarily in the endoplasmic 
reticulum (ER) and are membrane bound (deBethizy and Hayes, 1989). This implies 
that they are within a lipoprotein matrix which is essential since the lipophilic substrates 
will part into the lipid membranes, the site of biotransformation. 
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a) Phase 1 enzyme reactions 
The most important enzyme systems involved in phase 1 reactions are the 
cytochrome P-450 (CP450) containing monooxygenases (deBethizy and Hayes, 1989). 
The CP 450 system is a coupled enzyme system containing two enzymes: NADPH-CP 450 
reductase and a haem-containing enzyme, CP 450. These enzymes are embedded in the 
phospholipid matrix of the ER as seen in figure 2.5) (Sipes and Gandolfi, 1991). 
Fig 2.5 . A schematic representation of the interaction of CP 450 
reductase and lipid (adapted from Sipes and Gandolfi, 1991). 
In reactions catalysed by CP 450, the substrate combines with the oxidised form 
ofCP450 (Fe
3+) and forms a substrate-CP450 complex (deBethizy and Hayes, 1989). This 
complex then accepts an electron from NADPH via NADPH CP 450 reductase which 
then reduces the iron in CP450 haem molecule to the Fe
2+ state. The reduced (Fe2+) 
substrate-C P 450 complex combines with molecular oxygen, which then accepts another 
electron from NADPH. The resulting oxygen species is highly reactive and unstable. 
One atom of this reactive oxygen is introduced into the substrate, while the other is 
reduced to water. The oxygenated substrate then dissociates, regenerating the oxidised 
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Cytochrome P 450 electron transport and oxidation ofaxenobiotic 
(Sipes and Gandolfi, 1991). 
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The glucuronsyltransferase is the principal phase 2 enzyme. Glucuronidation 
represents an important phase 2 conjugation reaction in the conversion of 
monooxygenase products to form glucuronides. The general mechanism of conjugating 
enzymes involves the activation of an endogenous molecule to yield a high energy form. 
Subsequent reaction of this activated form of the endogenous molecule with the 
xenobiotic produces the conjugate (deBethizy and Hayes, 1989). Uridine diphosphate 
(UDP) glucuronosyltransferase is the enzyme that carries out the reaction. It catalyses 
the interaction between the high energy nucleotide UDP-glucuronic acid and the 
functional group on the acceptor molecule (substrate) (Sipes and Gandolfi, 1991). 
Similar to the mono oxygenase, the glucuronosyltransferase is an integral part of the ER 
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and deeply embedded. Its interaction with the phospholipids of the membrane has a 
strong influence on its activity (deBethizy and Hayes, 1989). These enzymes also have 
a low order of substrate specificity which makes them ideally suited as detoxification 
enzymes. 
The Glutathione S-transferase enzymes are capable of conjugating relatively 
hydrophobic electrophilic molecules . This conjugate is less lipophilic, more water 
soluble and likely to be excreted in the urine. The transferases facilitate the nucleophilic 
attack of glutathione thiolate ion on the electron deficient atom of the relatively 
hydrophobic electrophilic xenobiotic. These enzymes catalyse the initial step in the 
formation of N-acetyl cysteine (mercapturic acid) derivatives of a diverse group of 
xenobiotics (Sipes and Gandolfi, 1991). The cofactor for the reactions catalysed by 
these enzymes is the tripeptide glutathione (GSH) which is composed of glycine, 
glutamic acid and cysteine. The enzyme catalyses the reaction of the nucleophilic 
sulfhydryl of glutathione with compounds containing electrophilic carbon atoms 
(deBethizy and Hayes, 1989). Conjugation decreases the reaction of these compounds 
with essential constituents of the cell. Much evidence indicates that glutathione 
S-transferase acts to detoxify reactive intermediates produced by the CP 450 system 
(Sipes and Gandolfi, 1991). There is however a delicate balance between the rate of 
formation of the reactive metabolites and their inactivation by GSH. Factors which 
affect this balance can dramatically alter the toxic potential of chemicals that produce 
toxicity via reactive intermediates. 
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A literary review of zearalenone (Zea) and aflatoxin Bl (AFB1 ) 
2.2 FUSARIOTOXICOSES 
2.2.1 Introduction 
Species of Fusarium cover a wide spectrum of activities ranging from fairly 
specific plant pathogens to those which are saprophytic on senescent plant materials. 
Due to their close association with plants and their relatively high water activity 
requirements for growth, fungi will have become established on a crop before harvest 
and may cause lots of problems in cereals following a late harvest after a wet summer 
(Smith and Moss, 1985). Fusarium species have been important for a number of years 
but in the last twenty years they have been extensively studied because the mycotoxins 
they produce can be a threat to animal and human health (Nelson et al., 1995). The 
production of these natural products (mycotoxins) depends on environmental 
conditions such as temperature and the availability of nutrients. In many areas of the 
world the major cereal crops such as corn and wheat are particularly susceptible to 
infection by these Fusarium species. The effects of consumption will ultimately depend 
on the types and concentrations of the mycotoxins present. The fungi produce a large 
number of metabolites such as zearalenone and the tricothecenes. These singly or in 
combination are thought to be responsible for numerous mycotoxicoses of farm animals 
and humans. Thus world-wide efforts have been directed towards the detection, 
isolation, quantification and assessing the biochemical effects of these toxins produced 
in grains and other commodities. 
To date, various Fusarium species have been analysed and their toxic properties 
investigated. Zearalenone (Zea), one of the less studied mycotoxins because of its 
speculative role in human diseases has now come to the forefront of investigations 
because of its oestrogenic properties such as anabolic and uterotropic activities in cattle 
and lambs fed contaminated mouldy corn (Kiang et aI. , 1978). There is now a growing 
public concern about the toxicological impact of Zea on humans since the recent 
occurrence of eostrogenic substances in food products, either as natural constituents or 
as contaminants (Goodman et aI., 1987). Their possible aetiological role in outbreaks 
of certain diseases is being evaluated. The presence of Zea, a secondary metabolite 
produced by Fusaria, in certain edible plants could constitute another potential source 
of oestrogen exposure to both animals and man (Goodman et aI., 1987). 
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2.2.2 Zearalenone 
In 1928, McNutt and co-workers discovered cases of vaginal prolapse in sows 
in Wisconsin (Christensen et al., 1967). The same phenomenon was later described in 
other parts of the United States of America, Australia, France and Canada. Pigs have 
been reported to be most affected because their feed is often rich in maize. Several 
fungi have been isolated from mouldy feeds causing such oestrogenic disorders. The 
most common fungus was found to be Fusarium graminearum. In 1967, Christensen, 
Nelson and Mirocha isolated an oestrogenic compound which they called F-2 toxin and 
which is now referred to as zearalenone. It has been found to display the highest 
oestrogenic activity. 
Fig. 2.7 Zearalenone, [6-( 1 O'-hydroxy-6'-oxotrans-l-undecenyl)-b-resorcyclic 
acid lactone], a non steroidal fungal oestrogen (Cox and Cole, 1981). 
Due to its frequent occurrence and frequent detection, Zea has been studied in 
more detail than many of the other Fusarium toxins. It is slightly soluble in water 
(O.002g/ml) but freely soluble in methanol, ethanol and acetone (Cox and Cole, 1981) 
Because it is a phenol with weak acidic properties, its solubility is greatly enhanced in 
aqueous alkali. 
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2.2.3 A survey of in vitro studies assessing the toxicity of zearalenone 
This toxin has been implicated in serious reproductive and toxicological 
problems related to farm animals fed contaminated mouldy corn, causing 
hyperoestrogenic syndrome and subsequently a large economic loss (EI-Sharkawy, 
1'991). Zea and some of its metabolites have been found to exhibit anabolic and growth 
promoting activities in cattle (Katzenellenbogen et aI., 1978). This led many 
investigators to undertake a wide range of in vivo and in vitro metabolic studies. Its 
toxicological properties are still unclear but it has been reported to be potentially 
carcinogenic. It has however been suggested that Zea was a contributing factor in 
cases of precocious sexual development of human infants in Puerto Rico (Goodman et 
aI., 1987). Consequently there is increasing concern about the potential risk of Zea to 
humans not only from direct exposure to contaminated cereals but also through foods 
from animals exposed to Zea-contaminated feeds (prelusky et aI., 1989). Any health 
risks to humans of the resorcylic lactones will obviously depend on the combination of 
their potency and the magnitude of exposure to them (Goodman et al., 1987). This 
review aims to look at the in vitro studies conducted in order to assess the toxicity of 
Zea and its derivatives. 
2.2.4 Zearalenone vs oestrogen 
An oestrogenic syndrome involving marked changes in the reproductive tract of 
swine has long been recognised in animals that consumed mould-infected corn. In 1962 
Stob and co-workers isolated a compound from infected corn which appeared to be 
responsible for the eostrogenic syndrome which resulted in vulva hypertrophy, vaginal 
eversin and enlarged mammary glands and growth promoting activity. This compound 
was identified as Zea. 
The biological effect of oestrogens in target tissues depends on the presence of 
cytoplasmic oestrogen receptors. The steroid-receptor complex translocates into the 
nucleus, binds to DNA template and in turn stimulates cellular RNA and protein 
synthesis. The binding affinity of the receptor for oestrogenic molecules is extremely 
strong and steroid specific. However many nonsteroidal compounds can bind to 
oestrogen receptors and exhibit either agonistic or antagonistic effects of oestrogenic 
function (Kiang et aI. , 1978). Investigations carried out by Kiang and co-workers 
(1978) showed that Zea derivatives can compete with oestradiol for binding with 
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cytosol eostrogen receptors. z~) was found to initiate the translocation of cytosol 
receptors into the nuclei and thus increase the number of nuclear binding sites. It was 
also found to increase rat uterine weight and increase the protein content as seen by the 
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The change of wet weight and protein content of rat uteri following a 
dose oftrans-Zea (200Jlglml) (Kiang et al., 1978). 
This biochemical characteristic of Zea derivatives 'could explain the infertility 
observed in animals after the ingestion of a large quantity of zearalenone from 
contaminated feed (Kiang et al. , 1978). The binding of Zea to oestrogen receptors is 
structurally specific. Steroid hormones such as progesterone and testosterone do not 
bind to oestrogen receptors which suggests that steroid structure itself is not solely 
responsible for specific binding (Kiang et al., 1978). 
In mice Zea was found to increase the permeability of the uterine to uridine and 
amino acids and was accompanied by the subsequent increase in protein and nucleic 
acid synthesis in a manner similar to the effects of natural oestrogen E2 . In rats Zea 
binds with oestrogen receptors of both the hypothalamus and hypophysis. This would 
suggest that Zea affects the eostrogen feedback system through the oestrogen receptor 
of the rat brain. 
Fig 2.9 
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From Zea over three hundred derivatives have been synthesised 




Zearalanol is produced commercially as an anabolic agent to improve growth 
rate and feed efficiency in feedlot cattle (Katzenellenbogen et al., 1978), 
Katzenellenbogen and co-workers (1978) compared the interactions of these 
derivatives to that of oestrogen, 
Fig 2.10 
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Dose response curves showing the uterotropic activities of oestrogen 
(E2) and Zea derivatives (P-1496 & P-1492 & P-1560) 
(Katzenellenbogen et al., 1978). 
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From the results it was concluded that much higher doses of these compounds 
are required to achieve maximal uterotropic response. It was found that uterotrop~c 
potency increases in the order ofP-1496 > P-1492 > P-1S60. In the rat uterus these 
compounds induce the synthesis of uterine growth. In mammary tumour cells these 
derivatives stimulate cell proliferation and processing of nuclear oestrogen receptors. 
2.2.5 Metabolism 
Veno (1993) suggested that Zea is reduced to a-zearalenol by zearalenone 
reductase which is about ten times more oestrogenic than the parent compound. 
Kiessling and co-workers(1978) investigated the metabolism of Zea in rat liver. They 
found that Zea was metabolised along two main pathways. One is conjugation by 
glucuronic acid and the other mechanism is a reduction of Zea to an isomer of 
zearalenol possibly catalysed by a hydroxysteroid dehydrogenase which is normally 
involved in the metabolism of steroids. This may lead to a disturbance of steroid 
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metabolism during a prolonged intake of Zea. Nogowski and co-workers (1984) also 
investigated the metabolic properties of Zea. They investigated the effect of Zea on 
liver and muscle glycogen content. Zea (200~g/day) was found to increase glycogen 
content in both liver and muscle. 
Table 1 
Group 







Liver glycogen (mg/g) 
Muscle glycogen(mg/g) 
The effect of Zea on uterus weight, pancreatic hormones and 
carbohydrates of overiectomized female rats (Nogowski 
eta!',1984). 
Control lea (20~~ml) lea{200~g/ml) 
39.0 ± 3.0 42.8 ± 4.3 86.4 ± 5.9 
22.5±2.6 24.1± 2.2 34.3 +3.9 
464 ± 53 363 ± 33 337 ± 14 
1.27± 0.20 1.50 ± 0.18 2.48 ± 0.23 
5.04±0.27 4.68±O.32 5.04 ±0.22 
54.5 ± 2.5 59.6 ± 3.4 64.1 ± 1.9 
2.05±O.08 2.45 ±0.13 2.52 ± 0.13 
2.2.6 Zearalenone related diseases 
Zearalenone and related compounds may have a useful role in pharmacy such as 
regulating problems during menopause. !3-zearalenone a derivative of zearalenone, has 
been considered as a potential treatment for menopausal syndrome in women 
(Goodman et al., 1987). Some derivatives may act as contraceptives while others, 
added to animal feed may increase the growth of farm animals (Mirocha, 1970 as cited 
by Moreau, 1979). There have however been suggestions that lea may account for the 














In assessing the risk of Zea to humans, some measure of its oestrogenic 
potency was investigated. Typical signs of hyperoestrogenism are prolonged oestrus, 
changes in libido, infertility, increased incidence of pseudopregnancy, increased 
mammary gland development and abnormal lactation (Goodman et aI. , 1987). In a 
recent outbreak of precocious puberty changes in thousands of young children in 
Puerto Rico, Zea and zearalenol were considered as possible causative agents 
(Rodrigeuz, 1984 as cited by Goodman et aI. , 1987). The effects seen included 
premature telarche, premature pubarche, prepubertal gynecomastia and precocious 
pseudopuberty. It was further reported that Zea or a derivative was present in the 
blood of some of the patients. 
It was locally found that a young African boy showed signs of hyperoestrogenic 
activity when his chest resembled well developed breasts ( Proceedings of 10th South 
African Biochemistry Symposium, 1987) (Fig 2.11). 





After extensive investigations, it was concluded that aflatoxins are the most 
potent secondary metabolites produced by the fungal moulds, A. flavus and A. 
parasiticus. Many adverse human health effects have been linked to the dietary 
contamination of foods with this particular mycotoxin. The relationship between 
aflatoxin ingestion and liver cancer has been well established (Smith & Moss, 1985). 
Throughout the world, aflatoxins have been considered to be a major public health 
hazard. It has been found that developing countries show a high percentage of 
aflatoxin related diseases due to the inadequate storage facilities which encourages the 
growth of moulds (See 2.2.2). An IARe-convened Working Group in 1992 concluded 
that "naturally occurring aflatoxins are carcinogenic to humans" (Wild, 1993). This 
conclusion was based on the hepatocarcinogenecity of aflatoxins in animals and 
epidemiological evidence linking aflatoxin exposure to a high risk of hepatocellular 
carcinoma. Although over 100 fungal toxins have been identified and characterised 
during the "mycotoxin gold rush era", aflatoxins still remain the most important human 
and veterinary health hazard and their study dominates mycotoxin research (Wild et al., 
1986). 
2.3.2 Aflatoxin Bl and Aflatoxin B2 
The discovery of the Turkey- X disease in England in 1960, initiated the 
resurgence of interest in mycotoxins. The X was used to denote the unknown origin of 
the disease. Subsequently the etiological agent was found to be the Brazilian peanut 
meal which was contaminated with toxins produced by A. flavus, an ubiquitous mould 
(Wogan, 1966). The aflatoxins constitute a variety of structurally related metabolites 
which differ in their biological effects. The major naturally occurring aflatoxins are 
aflatoxin Bl, B2, Gl and G2. Aflatoxin Bl occurs most widely in the greatest amounts 
and has the greatest biological activity of this group of toxins 
Wark done on the effects of AFB2 (dihydro-AFB 1) in rats showed that its 
potency is 150 times reduced compared to that of AFBl (Wogan, 1966). However it is 
more active in other systems such as duck. Roebuck and co-workers (1979) showed 
that duck liver metabolises AFB2 much more actively than do mammalian species and a 
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significant pathway in this transformation is 2,3-desaturation to form AFB 1. The latter 
compound would then be available for activation through the epoxidation pathway as in 
other species. 
2.3.3 Biochemical effects 
The aflatoxins are primarily metabolised by the microsomal mixed function 
oxygenase system, a complex organisation of cytochrome-coupled, oxygen and 
NADPH dependent enzymes localised predominantly in the ER of liver cells, but also 
I 
present in the kidney and lungs. These enzymes catalyse the oxidative metabolism of 
AFBl resulting in the formation of various hydroxylated derivatives and the highly 
reactive epoxide metabolite. The detoxification of AFBl is done by the enzymatic 
conjugation of the hydroxylated metabolites with sulphate or glucuronic acid to form 
water soluble sulphate or glucuronic esters which are ultimately excreted in urine or 
bile. The alternative route for the removal of AFBl involves the enzyme - catalysed 
reaction of the epoxide metabolite with glutathione. A few of the known detoxification 
pathways of AFBl metabolism are depicted in Fig. 2.12. It has been extensively 
documented that during the course of AFBl metabolism the reactive metabolite (AFB 1-
8,9 epoxide) can react with various nucleophilic centres in cellular macromolecules 
such as DNA, RNA and protein with the consequences being opposite to that of 
detoxification. posing a biological hazard to the cell. The possible pathways by which 
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Fig 2.12 The metabolic transformation of AFBl (Adapted from Groopman et aI., 
1988). 
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2.3.4 A survey of in vitro studies assessing the toxicity of AFB 1 
Much effort has been made by researchers involved in mycotoxicological studies 
to investigate the association between aflatoxin exposure and related health effects in 

















Aflatoxin ingestion and liver cancer incidence in humans (Groopman et 
al., 1988) 
Dietary Cases of liver Incidence in Cases of liver Incidence in 
aflatoxin cancer in men. men cancer in woman 
intake (nglkg No.l100,000 women. 
body population per No.l100,000 
weight/day year I>er year 
3-5 1 3.1 0 0 
6-8 13 10.8 6 3.3 
10-15 16 12.9 9 5.4 
5-9 9 7.0 2 1.4 
9-14 24 14.8 5 2.2 
15-20 4 18.7 0 0 
43-53 35 26.7 7 5.6 
5-8 - - - -
45-77 - - - -
222 - 35.0 - 15.7 
Classical epidemiological studies have been hindered by the lack of adequate 
dosimetry data on aflatoxin intake, excretion and metabolism (Groopman et al., 1988). 
The carcinogenic potency of AFB 1 has been well established in many species of animals 
including rodents, primates and fish. Such experiments have often examined dose -
response characteristics, route of administration, size and frequency of dose, sex and 
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age of test animal. The effects of various factors on carcinogenic responses have been 
investigated, including the diet, liver injury, hormonal status and microsomal enzyme 
activity (Groopman et aI. , 1988). Many studies have also examined the potency and 
structure activity relationships of aflatoxin congeners, structural analogues and 
metabolites as inducers of liver tumours. This review will attempt to collate and 
evaluate what is known about aflatoxin metabolism, together with the relationship it 
may have with toxic lesions observed, using in vitro models. 
2.3.4.1 Investigations using rat hepatocytes and human cell lines 
Most of the published information on AFBl carcinogenecity has been obtained 
from studies on rats which are highly susceptible to the toxin. Cultured rat hepatocytes 
form an integral part of a series of in vitro test systems which have been developed 
during the last few years. Reports from several laboratories indicate wide interest in the 
use of rat hepatocytes in primary monolayer culture for the study of xenobiotic 
metabolism and carcinogenic detection, while much work in the last twenty years has 
been in assessing human exposure to aflatoxins via a number of systemic 
epidemiological studies (Groopman et aI., 1988). 
2.3.4.2 The formation of the AFBl 8,9 epoxide 
The effect of chemical carcmogens and other xenobiotics on hepatic 
microsomal enzymes involved in the metabolism of foreign compounds is becoming 
increasingly important since it is these "drug metabolising enzymes" which affect the 
resulting physiological properties of the parent compound. Gurtoo and Chandrakant 
(1975) utilised an in vitro microsomal-mixed function oxygenase system (MFO) to 
convert AFBl into reactive metabolites that bind covalently to macromolecules such as 
proteins and RNA. Gurtoo (1973), showed that AFBl binds noncovalently to liver 
microsomes while its metabolite binds tightly and possibly covalently to liver 
microsomes. Pre-treated microsomal preparations with various combinations of AFBl, 
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The spectral difference between two sets of microsomes pre-treated 
with NADPH and AFBl (Spectrum A) while spectrum B includes SKF-
525A (Gurtoo, 1973). 
Spectrum A in the figure is the spectral, difference between two sets of 
microsomes pre-treated with NADPH in the presence and absence of AFB1. This 
spectrum shows two peaks, one at 363nm due to bound AFBl and the other at 412nm 
due to a bound metabolite. Spectrum B indicates the difference between microsomes 
pre-treated with AFB 1, NADPH and SKF-525A and those treated with NADPH only. 
Under these conditions the formation of the metabolite is prevented and only a peak at 
363nm is detected due to bound unmetabolized AFB1. 
Jen-Kun Lin and co-workers (1978) showed the formation of2,3-Dihydro-2,3-
dihydroxyaflatoxin B 1 (dihydrodiol) as a major metabolite in the incubation of AFB 1 
with rat and hamster liver microsomes. The formation of this product was cytochrome 
P450 and reduced NADPH dependent. 
The metabolic formation of the epoxide is supported by the release of the 
dihydrodiol and 2,3-dihydro-2-(guan-7-yl)-3-dihydroxyaflatoxin Bl as products of the 
weak hydrolysis of nucleic acid AFBl adducts formed in rat liver microsomes in vitrQ. 
From this one can deduce that the capacity of microsomal enzymes to form the 8,9 
HO 
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epoxide is one of the factors that determine the hepatocarcinogenecity of AFB 1. N eal 
and Colley (1978) examined the metabolism of AFB1 in vitro in rat liver microsomal 
preparations using high Pressure Liquid Chromatography (Hplc). It is metabolised by 
rat liver to form a variety of metabolites (phenols, hydroxy compounds and epoxides). 
The only major non microsomal route of metabolism reported is the reduction to 
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Fig 2.14 The metabolism of AFB1 (Neal and Colley, 1978). 
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The biological potencies of the non polar chloroform soluble metabolites all 
appear to be less than that of AFBl except for AFMl (Campbell, 1970). The 
production of the dihydrodiol could reflect a detoxifying hydrase reaction subsequent to 
the primary activation of AFB 1 by epoxidation. The formation of the dihyrodiol may 
therefore indicate the AFB 1 activating capacity of the microsomal preparation. N eal 
and Colley (1978), found AFMl , AFQl and the dihydrodiol as principal metabolites of 
AFBl using Hplc. They further found that AFMl underwent very limited microsomal 
metabolism to more polar compounds. AFP1 was metabolised in the absence of 
NADPH to an unidentified metabolite. As discussed earlier , CP 450 is the principal 
enzyme system involved in the oxidative biotransformation of AFB1. Human 
microsomes show a rapid NADPH dependent metabolism of AFB1. It was shown that 
AFQl appears to be the major detectable metabolite produced by human microsomal 
metabolism in contrast to other laboratory animals in which AFB l-8,9,-dihydrodiol is 
the major soluble metabolite (Moss, 1985). Moss and Neal (1985) showed that human 
liver metabolises AFBl rapidly to AFQl and possibly to a lesser extent to AFB l-8,9-
epoxide (Table 3). The apparent lack of capacity for AFB1-GSH production by human 
post microsomal supernatant suggests that any AFB l -8,9-epoxide produced is likely to 
undergo macromolecule binding rather than detoxification. 
Table 3 The production of AFBl metabolites (Moss & Neal, 1985). 
Sample Sex Rate of Recovery of AFBJ diol AFQJ AFMJ 
AFBJ soluble production production production 
metabolism aflatoxins (%) (%) (%) 
(nmoles/mg after 30 min 
protein/min) (% initial 
AFBJ) 
1 M 2.7 35 27 73 trace 
1 M 2.14 45 10 90 not detected 
1 M 1.5 50 18 68 14 
2 F 0.63 59 20 77 not detected 
2 F 0.73 65 26 74 not detected 
3 M 1.027 46 26 65 trace 
3 M 1.44 42 26 72 
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Ramsdell and co-workers (1991) showed that the proportion of AFBl 
converted to the highly reactive epoxide in microsomal incubations varies with 
substrate concentrations and investigated the effects of cP450 111A4 as the principle 
system responsible for the epoxidation of AFBl by human liver microsomes. They 
found that P450111A4 enzymes are capable of AFBl epoxidation at relatively high 
substrate concentrations (124/lM) and at lower substrate concentrations (16/lM) other 
enzymes are involved which would be typical for dietary exposures as shown by the 
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The inhibitory effect of an antibody against rat cP450111A4 on AFBl . 
activation (Ramsdell et al., 1991). 
Geurgerich and co-workers (1992) used a number of different approaches to 
determine the catalytic selectivity of individual human enzymes towards 
procarcmogens. They found that at low AFBl concentrations, the results of 
immunoinhibition, chemical inhibition and correlation experiments are consistent with 
the view that both AFBl 8,9-epoxidation and hydroxylation are catalysed primarily by 
P450111A4. 
2.3.4.3 Aflatoxin Bl -protein complexes 
Aflatoxin B 1 has been found to act as a hepatocarcinogen at extremely low 
levels. It has been suggested that metabolites of AFBl may interact mainly with a few 
critical macromolecules to bring about this malignant transformation. Several studies 
have therefore been directed to the study of aflatoxin macromolecule adducts formed in 
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liver during hepatocarcinogenesis, in order to identify important interactions in the 
oncogenic process. Mainigi and co-workers (1977) described different kinds and 
amounts of aflatoxin-protein complexes present in liver cytosol throughout 
hepatocarcinogenesis produced from AFBl. Liver cytosols were incubated with [3H] 
AFBl at a concentration of 1.26 to 1.54!lCilml cytosol for 2 hours at 1 to 4°C with 
stirring. Cytosols were then subjected to molecular sieving through Sephadex G-25 
gel. The isolated macromolecules were resolved either according to molecular size by 
filtration through Sephadex G-200 gel or according to a combination of molecular 
charges and sizes. In this particular study 8 classes of aflatoxin-protein complexes were 
found in the liver cytosol according to molecular size and 6 according to charge size. 
Swenson et al. (1974) reported that AFBl gives rise to more adducts of nucleic acids in 
rat liver than of proteins which has been offered as evidence to support the possible role 
of DNA as the crucial target of this hepatocarcinogen. The unusual potency of AFBl 
may result from a capacity to inflict multiple molecular insults on target cells. The table 
below indicates the molecular weights and amounts of various molecular size species of 











Molecular weights and amounts of various molecular size 
species of aflatoxin-protein complexes in rat liver cytosol 
(Swenson et aI., 1974). 
Molecular In vivo In vivo In vitro 
weight 18hours 48hours 
>300,000 6 10 6 
2-3 X 105 5 5 4 
180,000 18 13 16 
120,000 18 9 6 
80,000 18 16 8 
45,000-50,000 26 21 59 
22,000-26,000 18 19 12 
12,000-15,000 8 7 5 
An interesting 4S complex formed may originate from the binding of labelled 
toxin to several glutathione-s-transferases, which have that molecular weight in 
common. Mainigi and Sorof (1974) have provided evidence in support of a model in 
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which the target protein acts as a cytoplasmic receptor that protects activated 
carcinogen and carries it to the cell nucleus during carcinogenesis. From these studies 
it was concluded that the specific, weakly basic carcinogen-protein complexes 
containing activated carcinogens may act to direct or restrict the interactions of the 
activated carcinogens to specific sites on DNA. The formation of AFBl -DNA adducts 
is implicated in tumour formation but the mechanism by which AFBl or its derivative is 
translocated into the nucleus is still unclear. The existence of cytosolic Ah receptor and 
binding proteins of lipophilic carcinogens involved in the metabolism of xenobiotics has 
been documented. Ch'ih and co-workers (1993) utilised equilibrium dialysis to 
prepare a number of AFB1-protein complexes and studied their translocation into the 
nucleus. Results indicated that the ligand protein complex is selectively translocated 
into the nucleus. The highest binding was exhibited by pyruvate kinase (Table 5). 
Table 5 The formation ligand protein complexes ( Ch'ih, 1993). 
Protein AFBj-DNA adducts 
(fmollmg DNA) 
Albumin 1.77± 0.88 
Albumin-NLS 13.69 ± 0.20 
Histones 5.51± 1.16 
Pyruvate kinase 0.28± 0.10 
Since AFB 1 is lipophilic and known to bind to a number of proteins it is unlikely 
that it enters the nucleus unbound. It is possible that it translocates across the nuclear 
pore as a ligand-protein complex by binding to proteins destined for the nucleus 
(histones), thus increasing its uptake, activation and damage to DNA, leading to an 
increased risk of developing cancer. 
2.3.4.4 DNA adduct formation 
Rodent cell cultures have been developed for the study of the mechanism of 
malignant transformation by chemical and physical carcinogens. It has been 
demonstrated that AFBl binds to both native and denatured DNA and lowers the RNA 
content. It has therefore been suggested that the extreme toxicity and carcinogenecity 
of AFBl may be the direct result of the affinity of this toxin for DNA. DNA adducts 
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are considered to be the promutagenic lesions which give rise to initiated cells required 
for transformation and carcinogenesis. The principal product of DNA binding in the 
liver of rats and other systems is the N7-guanine derivative (8,9-dihydro-8(n7-guanyl)-
9-hydroxyAFB1). There exists a correlation between the level of AFBI-DNA adducts 
formed and the likelihood and extent of tumourigenesis. Rechtel as cited by Eaton 
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A direct relationship between AFBl concentration and DNA adduct 
formation (Eaton, 1994). 
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Hertzog (1980) suggested that in rat liver DNA two competing reactions occur, 
both of which may be important in carcinogenesis. Firstly, the release of AFB1-guanine 
adducts from DNA would give rise to apurinic sites which would eventually lead to 
DNA strand breaks and secondly, AFB1-guanine is attacked at the 8'position of 
guanine by -OH ions. The production of apurinic sites and possible apurinic 
endonuclease activity with the production of strand breaks might be a mechanism for 
mutation induction or tumour initiation. Essigman and co-workers (1976) used 
perfused rat liver to study carcinogen-DNA adduct formation from AFB1. It was 
found that binding levels obtained were similar to those demonstrated in DNA from 
animals receiving similar doses. The perfusion of rat livers with AFB 1 under controlled 
conditions resulted in the dose dependent covalent binding of the carcinogen to DNA. 
The relationship between AFBl dose and binding to liver DNA is shown in figure 2.17. 
Fig 2.17 
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(Essigmann et al., 1976). 
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The mouse embryo fibroblast line C3H1lOT1/2 clone 8, was found to be able to 
activate AFBl and form covalent AFB(DNA adducts which are identical to adducts 
formed in human tissue (lungs, bronchi, colon). Wang and Cerutti (1980) aimed to 






I~-~-~--~~ o 2 .. 0 
pMOl AFS,' O,U, AODUCTS PER MOL ON ... · ' 
A linear relationship between the log of the colony-forming ability of r 
10T1I2 cells and the initial concentration of AFBI-DNA adducts (Wang 










AFBl adduct formation accounted for as two components :structure 1 
(AFB1-N7-Gua) and structure 11 (AFB1-FAPyr) (Autrup et al., 1979). 
Extensive reviews have shown that AFB 1 can be activated by cultured human 
tissues and the major adduct formed between DNA and AFBl is chromatographically 
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identical to the adduct formed in rat liver. Autrup and co-workers (1979), showed that 
two different human tissues (bronchus and colon) can metabolise AFB 1. The adducts 
formed between AFBl and DNA in both the human bronchus and colon were 
qualitatively similar to the adducts formed in rat liver. They found that over 70% of the 
AFBl binding in bronchus DNA was accounted for as two components, 1 and 11 which 
were chromatographically identical to AFBI-N7-Gua (structure 1) and an adduct 
identified as 2,3-dihydro-2-(N5-formyl-2' ,5' ,6' -triamino-4' -oxo-N5-pyrimidyl)-3-
hydroxy aflatoxin Bl (AFBI-FAPyr)(Il) (Fig 2.19). They have proposed that the 
formation of adduct 1 induces a positive change in the imidazole ring of guanine and 
this possibly alters the primary structure of DNA in the vicinity of the adduct. 
This substitution weakens the covalent bond between the adduct and the DNA 
backbone which may facilitate its rapid chemical or biochemical removal. Structure 11 
would not carry a positive change in DNA and its glycoside bond would be more 
chemically stable than that of structure 1. These observations add AFBl to the list of 
chemical procarcinogens metabolised by cultured human tissues and in which the 
carcinogen-DNA adducts are similar to the adducts formed in animal tissue susceptible 
to the carcinogenic action of AFB 1. 
In 1976, Grant reported the occurrence of colon carcinogenesis in two men who 
had worked with purified aflatoxin. Patient 1, a 42 year old biochemist developed 
abdominal pain and bowel obstruction . He died in 1972. Ten years previously he 
began research into the chemical nature of aflatoxins. For several years he purified the 
chemical by scraping it from chromatographic plates accumulating 1 mg lots for 
research. Patient 2, a 28 year old student developed lower quadrant and periumbilical 
cramping pain. A grade ten adenocarcinoma was resected. He spent twelve months 
purifYing aflatoxins. There was no ventilation hood were he worked but he recalled 
some dust exposure as a potential source of contamination. 
Even though in most species the carcinogenic effects of AFBl is expressed in 
the liver, the extreme toxicity and carcinogenecity of AFBl suggests that in human 
exposure, other organs may also be effected. Stoner and co-workers (1982), studied 
DNA binding and adduct formation of AFBl in cultured bladder and tracheobronchial 
explants from human, monkey, dog, hamster and rat (Fig 2.20). Explants were exposed 
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to eH] AFB 1. After 24 hours, epithelial cell DNA was isolated. Binding was found to 
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Elution profiles of AFBI-DNA adducts fonned by bladder explants of 
human, monkey, dog, rat and hamster. The ring-opened adduct 
elutes in fractions 36-38 while the closed ring structure elutes in 
fractions 45-47 (Stoner et al., 1982). 
,. 
They have however explicitly stated that in vitro exposure to extrahepatic 
tissues to increased AFBl concentrations (O .lIlM) represents an artificial situation, 
especially since in vivo the liver is both the target organ and the primary site of 
metabolism of AFB 1. Although AFBl has been detected in human urine and lung 
tumour tissue, the in vitro demonstration of AFBI-DNA adduct fonnation in 
extrahepatic tissue" is insufficient evidence for postulating a role of AFBl in the 
pathogenesis of respiration and bladder cancer. In both tissues from all species, two 
major adducts were identified. In all cases the major adduct fonned representing 40 to 
79% of the total amount of [3H]AFB 1-DNA was AFB1-FAPyr while the AFBI-N7-Gua 
adduct represented 4 to 28% of the total. McCormick and co-workers (1985) looked 
at the cytotoxic and mutagenic effects of AFBI-DNA adducts in diploid human 
fibroblasts. They aimed to investigate the biological effects of AFB 1 in human 
fibroblasts as a function of concentration and initial number of DNA adducts. Because 
AFBl is activated into its highly reactive 8,9 epoxide, they substituted AFB1-dichloride 
(AFB1-CI2) a direct carcinogen which is a model for the proposed ultimate reactive 
metabolite of the epoxide. The Hplc results indicated that the major primary adducts 
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formed in the human cell line and in isolated DNA was the chemically unstable guanine 
derivative which could undergo a change in structure with time to form a more stable 
secondary adduct. The cytotoxic effect of AFB1-C12 was highly correlated with the 
presence of either of these guanine adducts. 
Leadon and colleagues (1981) investigated eXCISIon repair of AFB1-DNA 
adducts produced in normal fibroblasts (NF). Results showed that 40 to 60% of the 
adducts formed represented AFB1-N7-Gua which they suggested is formed almost 
exclusively as primary adducts in all tissues. It was also concluded that AFB 1-N7 -Gua 
adducts are spontaneously and enzymatically removed in NF. The AFB1-FAPyr formed 
in a secondary reaction from AFB1-N7-Gua represents the major lesion in NF and 
therefore transforms a repairable lesion into a non repairable one. 
Carcinogenesis in man has been correlated circumstantially with a deficiency in 
DNA repair in the hereditary disease Xeorderma Pigmentosum (XP3) (Sarasin, 1977). 
It was found that cultured fibroblasts from XP patients were defective in the repair of 
UV induced damage to their DNA and the unrepaired lesions might be responsible for 
skin cancer in these patients. It was therefore suggested that carcinogens may be tested 
by assaying DNA repair following administration to cultured cells. AFB1 has been 
shown to induce error-prone repair in Eschricha Coli, but requires metabolic activation 
in order to elicit its effects (viamicrosomes). It was found that repair deficient human 
cells (XP) are more sensitive to the mycotoxin than its wild type counterpart. Sarasin 
et al. (1977) demonstrated that AFB 1 activated by rat liver microsomal enzymes 
induces DNA repair replication in human W138 cells while AFBl itself does not. He 
also stated that a general toxic effect on cell metabolism rather than a selective effect on 
DNA repair may be responsible for the activity of procarcinogens and tumours 
promoters. 
Legator and Childs (1966) looked at the effects of AFB1 on thymidine kinase 
levels in a tissue culture environment knowing that the initiation DNA replication and 
cell proliferation is dependent on the activity of thymidine kinase. Results obtained 
showed the appearance of increased thymidine kinase which has been correlated with 
cell replication. 
41 
Table 6 The activity of thymidine kinase/flg DNA (Legator & Childs, 1966). 
24 hours 48 hours 72 hours 
control 1.07 1.24 1.18 
0.5ppm aflatoxin 2.49 3.34 21.1 
1.0ppm aflatoxin 1.59 6.78 31.7 
2.3.4.5 Effects on protein synthesis 
Among several biochemical effects observed in the rat liver, rapid and extensive 
inhibition of precursor incorporation into nuclear and cytoplasmic RNA follows the 
introduction of AFBl into the system. Dissociation of ribosomes from hepatic rough 
endoplasmic reticulum (rER) resulting from aflatoxin treatment of rats has been 
reported (Svoboda, 1966). AFBl affects rat liver protein synthesis by its suppression of 
amino acid incorporation into rat liver slices and isolated perfused rat liver. Harleyand 
Rees (1969) investigated the effects of AFBl on cellular and protein synthesis using 
Hela cells. This cell line was chosen for this purpose since the site and detailed 
processes of RNA formation in this cell line has been extensively investigated. It was 
found that 20 to 40flg of AFBl introduced to the cells showed marked inhibition of 
protein and nucleic acid synthesis. Measurements were made by comparing the 
incorporation of [3H] uridine, eH] thymidine and C4C] leucine into RNA , DNA and 









Exposure of mono layers to AFBl and the percentage 
radioactivity incorporated (Harley & Rees, 1969). 
% RNA % DNA % Protein 
inhibition inhibition inhibition 
34.5 11.4 11.0 
48.3 13 .8 25.8 
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It was shown that the maturation of the 45S ribosomal-RNA precursor was 
inhibited by AFBl, suggesting that the rate of ribosomal RNA synthesis is controlled by 
the maturation of the 45S RNA. It was deduced that the interaction of the toxin with 
the RNA component of the polyribosomes results in polysomal disaggregation. Moul'e 
(1973) looked at the action of the toxin on post-transcriptional events that convert 45S 
RNA into subribosomal particles in the rat liver cell. It was found that AFB1 allowed 
18S RNA to be excised and transferred to the cytoplasm where it appears in newly 
synthesised 40S subunits but impairs the subsequent emergence of the 60S particles. It 
has been postulated that AFB 1 or a derivative induces some alteration in the properties 
of the 60S particle. A specific defect in their stability could induce their immediate 
degradation inside the nucleus. It was concluded in this study that AFB1 does indeed 
inhibit RNA synthesis by defecting some step in the transcriptional mechanism. Studies 
were also made on the acute effects of AFB1 on nucleolar RNA (nRNA) synthesis. 
Sedimentation profiles obtained from density gradient centrifugation of nRNA showed 
that AFB1 inhibited the synthesis of rapidly sedimenting nRNA. Electron microscopic 
studies showed the segregation of nucleolar granular and fibrillar elements (Floyd, 
1968). 
In tissue culture studies, Legator (1960) used a heteroploid human embryonic 
lung cell line (L-132) and a diploid human embryonic lung cell strain to determine the 
effects of aflatoxins on cell growth, morphology and mitosis. Tissue culture allows one 
to construct a probable sequence of events to account for the effect of aflatoxin in this 
biological system. Legator (1960) found that the earliest effect of this toxicant is the 
suppression of DNA synthesis and mitosis, with the subsequent survival of the cell in a 
nondividing stage which is indicative of the presence of giant cells. This effect 
correlates with that of alykylating agents which are known to be mutagenic, 
carcinogenic and antineoplastic. Scaife (1970) used established cell lines of human 
kidney T cells , Hela and Chang liver cells to investigate the effects of AFB 1. He 
showed that AFB1 rapidly inhibits RNA synthesis in rat liver slices while the 3 human 
cell lines were more slowly effected. He attributed the difference in susceptibility of the 
cells in culture to the cytotoxic action of AFB1 by variations in cell permeability. 
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2.3.4.6 Effe-cts on Mitochondria 
Although the cells most affected in aflatoxin poisoning are those around the 
portal vein and bile duct, it has been reported that the mitochondria of rat liver cells are 
vulnerable to the toxin (Bababummi & Bassir, 1972). They also showed the markedly 
different susceptibilities of mitochondria from liver, kidney, heart and testis. It was 
found that the addition of ATP completely reversed the swelling of mitochondria to 







Degree of mitochondrial swelling following the exposure to AFB 1 
(Bababummi and Bassir, 1972). 
Degree of ATPase activity ATPase activity 
mitochondrial swelling (~oles) (~oles) 
Control Aflatoxin 20 xlO-s 
moles 
42 3.37 6.25 
18 3.49 5.58 
3 2.56 2.60 
2 2.38 2.31 
These findings suggested that toxic doses of aflatoxin may uncouple oxidative 
phosphorylation. As discussed earlier, the metabolic conversion of active carcinogens 
into electrophillic reactive forms is an important step in the induction of cancer with the 
CP 450 type mixed function oxygenases being the predominant enzyme systems 
responsible for the activation process. A CP 450 system has been localised in hepatic 
mitochondria. Niranjan and Avadhan (1980) performed experiments on the in vitro 
activation of hepatic carcinogen AFBl by rat liver mitochondrial and submitochondrial 
fractions. Their results show that intact mitoplasts free of detectable microsomal 
contamination can effectively metabolise AFBl into active components which 
subsequently bind to mitochondrial DNA, RNA and proteins. 
In 1982, both co-workers showed that the administration of AFBI to 
experimental animals resulted in the covalent binding to liver mitochondrial DNA at 
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concentrations 3 to 4 times higher than nuclear DNA which IS accompanied by 
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The effect of AFBl modification of template DNA on the transcription 
and translation processes using hepatocytes and mitoplast systems 
(Niranjan and Avadhan, 1980). 
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Both nuclear transcription and cytoplasmic translation are inrubited by 70 to 
80%. They concluded that mitochondria are the direct and possibly one of the major 
cellular targets for AFBl during carcinogenesis. Ramachandra and co-workers (1975) 
studied the in vitro effects of AFMl, AFBl and AFG1 on oxidative phosphorylation by 
rat liver with succinate as the substrate. They found that all these toxins inhibit the 
electron transport chain at Ix 10.4 M concentration and the site of inhibition is between 
cytochrome band c. It was further discovered that AFB 1 acts as an uncoupler at low 
concentrations and as inhibitors at high concentrations. 
2.3.4.7 The role of the glutathione system 
As in the case of the formation of electrophilic metabolites of many xenobiotics, 
conjugation with glutathione S transferase (GST) is believed to play an important role 
in the detoxification of AFB 1 in the liver. The GST are a group of isoenzymes 
catalysing the conjugation of reduced glutathione (GSH) with a wide spectrum of 
compounds possessing an electrophillic centre. The epoxide formed following AFB 1 
metabolism is capable of GST mediated conjugation with GSH. Species vary in their 
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sensitivity to aflatoxin toxicity which is in part dependent on their capacities to activate 
the toxin and their abilities to detoxify the reactive metabolite, by conjugation with 
GSH (Neal et al., 1987). Neal and co-workers compared the capacities of hepatic 
cytosolic GST isolated from some animal species representing a range of susceptibilities 
to AFB 1 cytotoxicity to catalyse the conjugation of GSH with several model substrates 
and also with microsomally-activated AFB 1 to ascertain which model substrates most 
closely parallel AFB1. 
It was found that the order of activities in the various liver fractions using 1-
chloro-2,4-dinitrobenzene (cDNBB) as a substrate were: mouse > pre-neoplastic 
nodular rat > guinea pig > control rat which paralleled the capacities of the cytosols to 
catalyse the formation of AFB1-GSH from microsomally activated AFBl and GSH. 
Neal and Green (1983) used a chicken liver microsomal system to investigate 
the formation of the AFBI-reduced glutathione (AFBI-GSH) conjugate in vitro. 
Chicken microsomes were used in this study because it was found to metabolise AFBI 
in a 30 minute incubation period and the metabolism proceeded almost exclusively via 
the presumed epoxide as indicated by the formation of AFBI-dihyrodiol-tris complex. 
An interesting feature observed was AFBI-DNA binding and glutathione 
conjugation in rats of different ages. Behroozikha and co-workers (1992) showed that 
immature rats are deficient in the hepatic key factors involved in biotransformation of 
AFB 1. Epoxidation of 3 [H]AFB 1 in the presence of liver microsomes from different age 
groups show that new-born rats are capable of catalysing only minimal AFBI-DNA 
binding. The amount of AFB1-GSH conjugate formed is also higher when adult GST is 
involved in the system. They therefore concluded that immature liver is less efficient 
than a mature organ in dealing with a chemical carcinogen. It has been shown that 
GST plays an important role in carcinogenesis by conjugating reduced GSH with 
electrophilic compounds and thus preventing binding to cellular macromolecules. 
These GST's exist in multiple forms of dimeric combinations of different subunits. On 
the basis of similarities in structural and kinetic properties, the mammalian GST's have 
been classified into three groups, i.e. a, Il, 1t family (Gopalan et al., 1992). Several 
GST classes are believed to be able to conjugate the AFBI -8,9-epoxide and GSH. 
Differences between mammalian species in susceptibility to AFB 1 carcinogenesis have 
been shown to be the result of differences in alpha GST conjugation of the epoxide 
suggesting that alpha GST activity may be a key factor in deterring species 
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susceptibility to AFB 1. Exposure of neonatal rats to xenobiotics such as phenobarbitol 
produced long term changes in hepatic enzymes not seen in adult animals exposed to 
the same compounds. These rats showed altered levels of DNA adduction as adults 
following the in vivo AFB1 exposure (Zanger et al., 1992). Zanger and co-workers 
exposed new-born male rats to diethylstilbestriol (DES) and other xenobiotics. They 
found · that neonatal treatment with DES resulted in a long term protection against 
AFB1 adduction to DNA, the putative initiating step in carcinogenesis. The protective 
mechanism seemed to be increased detoxification of the AFB l -8,9 epoxide resulting 
from increased cytosolic concentration of alpha class GST's and subsequent an increase 
in cYtosolic protein concentration. Geurgerich and co-workers (1992) found that 
human liver cytosol has considerably less GSH-S-transferase activity towards synthetic 
AFB18,9-oxide than rat liver cytosol. Of the human enzyme classes examined, the 
activities of the enzyme classes varied in the order of /..I. > a > n. 
Wong and co-workers (1992) studied the effects of geniposide (GP), an iridoid 
glycoside which was found to inhibit AFB1-induced hepatotoxicity and hepatic DNA 
binding in rats. Isolated from the fruit of Gardenia jasminoides, it was shown that GP 
reduced AFB1-induced DNA repair synthesis in a dose dependent manner in hepatocyte 
cultures and was found to elevate the metabolism of AFB 1 and decrease the formation 
of AFM1. The enzyme activities of GST and GSH peroxidase in AFB1-treated 
hepatocyte cultures are enhanced in the presence of GP thus reducing AFB1induced 
DNA repair synthesis through an increased AFB1 detoxification metabolism which 
provides one possible mechanism for the chemopreventive activity of GP. 
2.3.4.8 Oxidative damage 
Kuo-Huang Ling and co-workers (1967) also showed the effect of AFB1 on 
liver enzymes of the rat. Their studies revealed a decrease in the activity of succinate 
dehydrogenase and cytochrome c oxidase in the livers of toxin treated rats. It has been 
suggested that oxidative damage might contribute to the cytotoxic effects of AFB 1. 
Oxidative damage refers to the impairment of cellular components (enzymes, membrane 
lipids and proteins and nucleic acids) by reactive oxygen species such as superoxide 
radicals(02"), H20 2 and hydroxyl radicals (-OH). The latter reacts with cellular 
components to cause lipid peroxidation and DNA base damage. Shen and co-workers 
















hepatocytes. They used malonaldehyde generation and lactate dehydrogenase release 
as indices of lipid peroxidation and cell injury. Exposure to AFBI (72 hours) resulted 
in significantly elevated levels ofLDG being released as well as theMDA generation in 
cultured hepatocytes. These effects were dose dependent. MDA generation and LDH 
release were found to be inhibited by the addition ofsuperoxide dismutase and 
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Fig 2.22 Dose -response ofLDH release and MDA generation (Shen et al., 1995) 
2.4 Conclusion" 
There is at present a world-wide increase in awareness of the potential dangers 
posed to human health by mycotoxin contamination of food. The greatest concern 
today is probably the potent cancer risk posed by carcinogenic AFB1. This chapter has 
attempted to review the far reaching effects of AFB I and Zea in the hope of 
demonstrating the importance of this investigation in understanding the biochemical 
mechanism of action. 
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Chapter 3 
CELL CULTURE AND CYTOTOXICITY ASSAYS 
3.1 INTRODUCTION 
Since mycotoxins display a wide diversity of chemical structure, there are no 
common methods of analysis for these toxins. The most practical methods for detection 
are physico-chemical in nature. However, the ultimate test of toxicity of a mycotoxin is to 
experimentally test the effect of the suspected toxin in a living system (Smith and Moss, 
1985). During the last three decades the use of cell culture systems for investigations 
involving acute toxicity has increased. Several cell culture systems have been developed 
for rapid and economical in vitro tests for the identification of potentially toxic 
compounds and to characterise the toxicity of mycotoxins. The measurement of toxicity 
in vitro is purely a cellular event and hence the toxic response may be measured by 
changes in cell survival or metabolism. 
The need for sensitive, rapid, reliable and economical methods has led to the 
development of several standard assays. Such assays include the measurement of protein 
and DNA synthesis using an array of radiolabelling techniques. Recently, proliferation 
assays have become available for analysing the number of viable cells by the cleavage of 
tetrazolium salts added to the culture medium. In 1980, Mosmann described a Methyl 
Thiazol tetrazolium (3 -[ 4,5 -dimethylthiazol-2-yl] -2, 5-diphenyltetrazolium bromide) 
(MTT) reduction assay which is readily used in cytotoxicity evaluations. 
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3.1.1 The methyl thiazol tetrazolium(MTT) assay 
The use of MTT assays for various medical, microbiological and toxicological 
approaches: in vitro assessment of chemotherapeutic agents against tumour cells; 
assessment of radio sensitivity and cytotoxicological evaluation of chemical compounds 
has proven to be very successful (Hanelt et al., 1994). The principle of this reduction 
assay is that the tetrazolium salt is reduced to formazan (Fig 3.1) by the "succinate-
tetrazolium reductase" system which belongs to the respiratory chain of the mitochondria 
and is only active in viable cells (Mosmann, 1980). Another theory suggests that most 
cellular bioreduction ofMTT is associated with enzymes of the endoplasmic reticulum and 
involves the reduced pyridine nucleotides NADH. Succinate is a weak electron donor for 
mitochondrial MTT reduction (Berridge et al., 1996). Therefore cellular reduction of 
MTT is more related to the glycolytic rate per se and thus to NADH production rather 
than to respiration. Berridge et al. (1996) showed that MTT is reduced by microsomal 
enzymes that require pyridine nucleotides but agree that succinate can also act as an 
electron donor in MTT reduction through mitochondrial succinate dehydrogenase, 
however this reduction is slow and contributes little to total cellular MTT reduction. 
An increase in the number of viable cells results in an increase in the overall 
activity of enzymes in the sample. This augmentation in enzyme activity leads to an 
increase in the amount of formazan dye produced which directly correlates with the 
number of metabolically active cells in the culture. The formazan dye produced IS 
quantified spectrophotometrically. The following figure illustrates the MTT reaction. 
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MTT FORMAZAN 
The colour reaction: Yellow Blue 
Fig 3.1 . The chemical structures of the reactant (MTT) and the product (formazan) 
following the exposure of the tetrazolium salt to viable cells. 
This assay has been employed by Reubel et al. (1987); Hanelt et al. (1994) Shier et 
al (1991); Visconti et al. (1991); Dombrink et al. (1993) to mention a few who have 
successfully assessed the cytotoxicity of mycotoxins. To date, the results obtained have 
proven to be valid and reliable. 
3.2. CELL CULTURE 
3.2.1 The cell and its ' environment 
Presumably the best environment for growing cells is one providing as nearly as 
possible the conditions they experience in vivo. The essential requirements for an 
optimum cell culture environment are temperature, pH, the substrate, gas phases and the 
medium containing the necessary nutrients. 
a) Temperature 
One of the fundamental properties of living matter is the ability to perform 
chemical reactions at comparatively low temperatures. The optimal temperature for cell 
culture depends on the body temperature of the animal from which the cells were 
obtained. Therefore the temperature required for optimal growth of most human cell lines 
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is 37°C. The temperature at which cells can be stored in is usually at -70°C. Cultures can 
be stored for years in a frozen state, thus ensuring a continuous stock of cells in cases of 
loss due to contamination. 
b) Gas phase 
The most important gases are oxygen and carbon dioxide. Most dispersed cells in 
culture prefer low oxygen tensions. The depth of the culture medium influences the rate 
of oxygen diffusion to the cells and is normally within the range of 2 to Smm. Hepes(N-2-
Hydroxyethylpiperazine-N' -2-ethanesulphonic acid) (20mM) buffer is often added in the 
medium as an alternative to bicarbonate to stabilise the pH (7.4). HEPES is a satisfactory 
buffer in tissue culture media for the growth of many different cell types, mainly because it 
does not require an enriched atmosphere to maintain the correct pH. 
c) Substrate 
Most cells cultured in vitro have been grown as mono layers on an artificial 
substrate, in order to proliferate. Single-use polystyrene flasks provide a simple, 
reproducible environment for cultured cells. 
d) Medium 
The culture medium is by far the most important single factor in culturing cells. Its 
main function is to provide the physical conditions of pH and osmotic pressure required 
for survival and the complicated chemical substances required by the cells which it cannot 
synthesise itself Eagles minimum essential medium (EMEM), is a commercially prepared 
growth medium that contains essential amino acids, vitamins and salts. One of the most 
important nutrients required is glutamine which is required by the cells as an energy and 
carbon source (Freshney, 1983). Additional proteins are required to enhance cell growth. 
Various types of animal sera are used to supplement culture media preparations for cell 
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growth. The serum contains important proteins such as albumin, globulins and fetuin 
which act as carriers for minerals, fatty acids and hormones and have been found to be 
beneficial, promoting cell attachment to the substrate. The serum used is normally from a 
non-human source, to exclude human antibodies which could be inhibitory to the 
subsequent isolation of human viruses. Foetal calf serum (FCS) is usually used as an 
additional protein source. A complete culture medium (CCM) contains FCS, E11EM, 
glutamine and antibiotics (penicillin! streptomycin! fungizone) and therefore sustains 
continuous cell growth (Reubel, 1987). 
In addition to CCM, Hanks balanced salt solution (HBSS) containing inorganic 
salts, glucose and phenol red is routinely used to wash cultured cells in order to remove . 
cellular debris and dead cells. 
e) Trypsin 
Cells in culture are routinely sub cultured so that they can be propagated for the 
purpose of increasing cell numbers. Cells are removed from culture flasks using a variety 
of agents such as chelating agents, e.g., ethylenediaminetetraacetic acid (EDTA), or 
enzymes such as trypsin. Trypsin, an aqueous crude extract prepared from porcine 
pancreas is a proteolytic enzyme that aids in the digestion of connective tissue of cells and 
their cell membranes. Trypsin breaks down the intracellular matrix that binds cells to 
each other and the substr~te surface allowing adjacent cells to detach from each other. 
The optimum conditions for trypsin activity are at a pH range of 7.6-7.8 and a temperature 
of 37°C. 
3.2.2 The maintenance of the cell line 
The major requirement that distinguishes cell culture from many other laboratory 
techniques is the need to maintain asepsis. Media for the cultivation of cells are highly 
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nutritious not only for the cells but also for foraging invaders such as bacteria and fungi. 
The majority of these microorganisms have a much more rapid growth rate than cells and 
frequently produce toxins which are lethal to them. The most important part of cell 
culture is to eliminate contamination. The laminar flow cabinets with sterile air blown over 
the work surface affords greater control of sterility. 
Once the culture is seeded it needs a periodic medium change followed by 
passaging and sub culturing to attain confluence. The required time for cell growth in vitro 
is approximately one week. The characteristic features which determines whether or not a 
culture could be passaged includes cell density, rate of cell division and cell morphology 
(Freshney, 1983). 
3.3 MATERIALS AND METHODS 
All cell culture consumables were purchased from Polychem S.A. , unless otherwise stated. 
3.3.1 Materials 
a) Base medium 
Eagles Minimum Essential Medium with Earle's salts, Hepes, non essential amino 
acids and L-glutamine were routinely used. Constituents of each of these products are 
shown in appendix 1. Foetal calf serum (FCS) was heat inactivated at 56°C for 30 
minutes in a water bath with agitation. The FCS was filter sterilised using a 0.45~ filter 
(Millipore), aliquoted into 5ml vials and stored at -20°C until required. It was necessary 
to aliquot FCS since it was previously found that repeated thawing of heat inactivated 
FCS at 37°C resulted in the presence of granules, flocculent material and appeared turbid. 
To enhance cell growth, S to 10% FCS was added into the culture medium for growing 
cells while 0.5 to 5% was added when the cells formed confluent layers. To eliminate 
contamination, 100 units/ml penicillin, 100~glml streptomycin and 2 . 5~glml fungizone 
54 
were added to the culture medium. To 100ml of culture medium a 1 % 
penicillinlstreptomycinlfungizone mixture was added. 
b) HBSS 
The HBSS (Appendix 1) was added to wash off dead cells and cellular debris. 
c) Trypsin 
Lyophilised trypsin (2.5g) rehydrated with 20ml sterile distilled water was made 
up to lOOml with HBSS (calcium and magnesium free). The final mixture was then 
dispensed in 2ml aliquots in sterile Bijou bottles and stored at -20°e. 
d) Mycotoxins 
The mycotoxins zearalenone (Zea), Aflatoxin Bl (AFB 1) and AFB2 were obtained 
from CSIR. The epoxide derivatives of both Zea and AFBl were synthesised in the 
laboratory as outlined below. 
Synthesis of the AFBt-8,9-epoxide 
Synthesis of the AFB l-8,9-epoxide involved oxidation of AFBI (IOmg) with 
dimethyl dioxirane (DMOX) (lml) prepared from potassium peroxysulphate as a distilled 
O.05M solution in acetone (Baertschi et al. , 1988). AFBI was dissolved in acetone (2ml) 
and reacted with two fold excess ofDMOX. The reaction was complete within thirty 
minutes at room temperature. Solvents and excess DMOX were removed by evaporation 
under a stream ofN21eaving the epoxide which was recrystillized using methylene chloride 
(l .Sml). ('H NMR spectral data not shown). 
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The synthesis of the Zea epoxide 
Zea (10mg) was dissolved in dry analar acetone (2ml) to which was added 3 moles 
of dioxirane. The reaction was stirred in a recation vial for 12 hours at room temperature. 
A sample (Sill) was spotted onto a thin layer chromatographic plate (TLC) (10 cm x10cm, 
aluminium backed) and developed in hexane : DCM : ethanol (lS :10:lS). The plate was 
dried under a stream of warm air and tested for the presence of the epoxide. The dc plate 
showed more than one product. Using silica 7729, the components were separated using 
column chromatography. Comparison of the 'HNMR spectra of zearalenone supported 
the epoxide formulation. 
Mycotoxin stock solutions 
Stock solutions of the mycotoxins were prepared by dissolving O.S mg of each of 
the mycotoxins in 30111 ethanol, 170111 DMSO and 4.8ml CCM to produce toxin 
concentrations of O.lmglml. The stock solutions were then mixed and filter sterilised 
through O.4SIl filters (Millipore). Mycotoxin concentrations were prepared ranging from 
l.S61lglml to 251lglml by serially diluting the stock solutions with CCM. The controls 
were prepared in the same way without the addition of mycotoxins. 
e) Cell lines 
All cell lines were purchased from Highveld Biologicals. 
It has been recognised that several cell lines should be used in parallel to test the 
cytotoxicity of mycotoxins since toxin activating systems and effects may differ with the 
type of cells utilised. Therefore in this study AFB 1, AFB l-8,9-epoxide and AFB2 have 
been evaluated using both HepG2 (liver carcinoma) and AS49 (lung carcinoma) cell lines 
while Zea and its epoxide were assessed using HepG2 and Hela (cervical carcinoma) cell 
lines. The selection of the biological system must reflect the purpose of the study. For the 
study of organ-specific toxic mechanisms the similarity of the system to the in vivo target 
organ is essential. Since the liver is involved in the detoxification processes HepG2 cells 
were chosen to assess the cytotoxicity of the selected mycotoxins, especially AFBl. 
t) Preparation of the tetrazolium salt (MTT) 
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The MTT (Boehringer Manneheim) (5mg) was dissolved in phosphate buffered 
saline (lml) to give a concentration of 5mg/ml and filtered through a 0.45~ filter 
(Millipore) to remove insoluble residues of the yellow powder. The sterile stock solution 
was stored in the dark at 4°C. 
3.3.2 Methods 
a) Cell maintenance (Appendix 2) 
Culture flasks (25cm3) that contained cells with a 20% confluency needed a routine 
medium (supplemented with 5% FCS) change. The cells were passaged by discarding 
the medium with depleted nutrients. Flasks were then rinsed in HBSS (5ml) (37°C) to 
remove cellular debris and further washed twice in HBSS. Cell detachment was detected 
microscopically or with the naked eye as detached cells gave the medium a cloudy 
appearance. Complete culture medium (5ml) was then added and the flasks were capped 
and returned to the incubator (37°C) (Labotec). 
The medium from culture flasks of cells with 100% confluency was discarded and 
the cells were washed twice with HBSS described above. A Iml trypsin solution (0.25%) 
was added to the confluent flasks and trypsin digestion was allowed to proceed for 
approximately 1 to 5 minutes until microscopic observation showed the cells to have 
rounded off slightly but not to have become dislodged from the surface. The trypsin was 
then removed with a sterile pasteur pipette. To the flask was added 1.5ml CCM 
containing 10% FCS and the cells were dispersed in the solution by tapping the flask hard 
against the hand. The resultant suspension was repeatedly pipetted with a sterile pipette 
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to separate clumps of cells. To a 0.5 ml cell suspension was added 4rnl of medium for 
1:3 split. Flasks were then stoppered and incubated at 37°C without further disturbance 
to allow cells to attach to the substrate. 
Culture flasks containing confluent cells (not immediately required for cytotoxic 
testing) were stored by freezing the cells. The cells were first trypsinised and then 
suspended in freezing medium (EMEM + 10% Dimethylsulfoxide + 10% FCS). The cell 
suspension (1 rnl) was dispensed in 2 ml vials and stored at -70°C. 
When cells were required for cytotoxicity assays, the frozen cells were rapidly 
thawed by centrifugation (lOOOOg) at 25°C. The supernatant was discarded and the pellet ' 
was resuspended in fresh CCM (Irnl). The pelleted cells were dispersed in the culture 
medium by gentle shaking and finally transferred to a culture flask for incubation (37°C ). 
It is important to note that the procedures described thus far were all under strict aseptic 
conditions. 
b) The cytotoxicity assay 
A culture flask (25cm3) of confluent HepG2 cells were trypsiiiised and 
resuspended in CCM (5ml) to give a cell number of 4 x 104 cells/rnl, using a 
heamocytometer (Freshney, 1983). This cell suspension was dispensed (lOOjll) into each 
well of a 96 well microtiter plate giving a final cell count of (4000 cells/well). For each 
mycotoxin concentration (25jlg/ml to 1.56jlg/ml) there were five replicates of a lOOjll 
each. The control cells consisted of lOOjll cell suspension and a serial dilution of DMSO 
and ethanol (five replicates of 100jll each). Plates were incubated for 48 hours at 37°C. 
The MTT reduction assay 
After the cells were incubated (48hours) with the mycotoxins, the wells were 
aspirated to remove growth medium and 100jll of CCM together with 10jll of MTT 
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(5mg/ml) was immediately added to each well. The microtiter plate was then incubated 
(37°C) for a further four hours. Thereafter the supernatants were aspirated and 100~1 of 
DMSO (100%) was added to each well and incubated for another hour (37°C). Finally 
the optical density of each well was measured spectrophotometrically using a Bio-rad 
microplate reader at a wavelength of 595nm with a reference wavelength of 630nm. 
c) Phase contrast microscopy 
In order to investigate morphological changes under the phase contrast 
microscope, AFBl (25~g/ml) was added to a confluent layer of HepG2 cells in a 25cm3 
flask. The flasks were incubated (37°C) for 24 hours. Cells were microscopically 
examined to observe the cytotoxic effects of AFB 1. Cells were observed through a Zeiss 
inverted microscope and photographed with a Zeiss photomicroscope (using green filters). 
3.3.3 Statistical analysis 
The results from the cytotoxicity tests were analysed using a Statsgraphic Plus 
programme. Mean absorbances were expressed as % cleavage activity in comparison to 
cell controls (100%): 
% Cell viability = mean absorbance of toxin treated cells 
mean absorbance of control cells 
X 100 
The multiple box and whisker plots show the distribution of the range of data for each 
mycotoxin. It is useful for comparing parallel batches of data. The (x) denotes the means 
and the (-) denotes the median. Bar graphs representative of dose response curves 
showing absorbances as a measure of cleavage activities have also been plotted in an 
attempt to illustrate cell viability. 
59 
3.4. RESUL TS 
3.4.1 HepG2 cell growth and characteristics 
The HepG2 cells grew rapidly and after two days in culture the cells appeared 
scattered on the substrate. The cells were monolayered, polygonal, non-refractile, 
agranular and were tightly adherent to one another. After a week in culture cells appeared 
tightly packed together (Fig 3.2). Due to substrate limitations, the cells appeared more 
rounded as they tried to anchor in the intercellular matrix. Many cells displayed 
prominent nuclei which were observed by phase contrast microscopy (x1600). At a lower 
magnification (x 1 000) a confluent monolayer of cells was clearly observed, together with 
small areas containing cellular debris (Fig 3.3). 
3.4.2 HepG2 cells treated with AFBI 
After 24 hours incubation of confluent HepG2 cells with AFBl (251lg/ml) a distinct 
change in cell morphology was observed. Cell death was characterised by cell rounding, 
a detachment from the substrate and a marked inhibition of cellular growth (Fig 3.4). The 
culture medium also appeared turbid due to the high content of cellular material floating 
around. In addition cells appeared granulated. 
Fig 3.2 A phase contrast micrograph of HepG2 cells growing in a 25cm3 culture flask after a week in 
culture. The cells appeared bi-nucleated (x1600). 
Fig 3.3 A phase contrast micrograph of a confluent monolayer of HepG2 cells, after a week in culture 
attached to the substrate CS), with some cellular debris (x 1000). 
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Fig 3.4 AFBJ (251!g/ml) treated cells following a 24 hour exposure period, showing characteristic 
features of cell death such as cell rounding (er) (x1600). 
3.4.3 The colour reaction of the HepG2 cells 
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Following treatment with the respective mycotoxins the colour of the culture 
medium remained pink indicating viable cells (Fig 3.Sa). However, after the 48 hour 
incubation period of the cells with mycotoxins the cells reacted with the added tetrazolium 
salt (MTT) to form purple crystals. DMSO solubilizes the crystals and results in the 
production of a purple dye (formazan) (Fig 3. Sb). 
Fig 3.5a 
Fig 3.5b 
Cells exposed to a serial dilution of mycotoxins (251!glml to l.561!glml) in a 96 well 
microtiter plate for 48 hours. 
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Following the exposure period to the mycotoxins cells reacted with MTT to form purple 
crystals which are solubilized in DMSO to form a purple dye. 
3.4.4 The cytotoxic evaluation of AFBl and the AFBl-8,9- epoxide using HepG2 
cells 
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The results showed that HepG2 cells were particularly sensitive to the AFBI-8,9-
epoxide as compared to AFB1. The multiple box and whisker plot showed a significant 
difference (p = 0.007) in the distribution of the toxicity levels of AFBl and the AFB I-8,9-
epoxide at a 95% confidence interval (Fig 3.6.1). The bar graph representative of the dose 
response curve showing cleavage activity displayed a 72% cell viability for AFB 1 at 
25/lg/ml while the epoxide treated cells showed a 61% cell viability (Fig 3.6.2). At the 
lower concentrations (1.56/lg/ml) AFBl showed a 100% cell viability while the AFB I-8,9-
epoxide showed a 95% cell viability. The results suggests that the AFBI-8,9-epoxide is 
more cytotoxic than AFB 1. 
3.4.5 Effects of the AFBl-8,9- epoxide and AFB2 on HepG2 cells 
A comparison of the cytotoxic effects of the AFBI-8,9-epoxide and AFB2 using 
the multiple box and whisker plot showed a significant difference (p =0.02) at 95% 
confidence interval between the two toxins (Fig 3.7. 1). The bar graph (Fig 3.7.2) of each 
of the toxins showed a distinct difference in the distribution of the toxic levels for both 
toxins. Upon analyses of the bar graph it was found that AFB2 elicited minimal cytotoxic 
effects at all concentrations tested (100% cell viability at 25/lg/ml) while the AFBI-8,9-
epoxide showed significant cytotoxic damage (25/lg/ml showed only 58% cell viability). 
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3.4.6 The effects of AFBl and the AFBl-8,9-epoxide on A549 cells 
The A549 cells reacted differently to the exposure to AFBl and the AFBl-8,9-
epoxide. From the multiple box and whisker plot it was found that there was no 
. significant difference between the effects of both the parent toxin and its derivative (p= 
0.4) (Fig 3.8.1). The distribution of the toxicity levels was similar for both toxin 
treatments (Fig 3.8.2). This result suggests that the HepG2 cells are more sensitive to 
AFBJ than the A549 cells. From the dose response curve it was found that at 251lg/ml 
AFBl displays a 75% cell viability while the AFB l-8,9-epoxide displays an 80% cell 
viability and at 1.561lg/ml AFB 1 displayed 94% cell viability and the epoxide 97% cell 
viability. 
3.4.7 The cytotoxic effects of Zea and its epoxide on Hep G2 cells 
Results using a multiple box and whisker plot showed that there is a significant 
difference (p=0.0002) between the toxicity levels of lea and its epoxide with the latter 
being highly cytotoxic (Fig 3.9.1). The bar graph showed that at 251lg/ml lea displayed a 
66% cell viability while the epoxide displayed only an 18% cell viability (Fig 3.9.2). 
3.4.8 The cytotoxic effects of Zea and its epoxide using Hela cells 
When Hela cells were exposed to these mycotoxins there was no significant 
difference between the toxicity levels (p=0.7) (Fig 3.10.1). The absorbancy levels were 
similar in distribution. The bar graph showed an increased cell viability at 25 Ilg/ml with 
lea showing a 89% cell viability and the epoxide derivative showing a 96% cell viability. 
At 1.56 Ilg/ml lea showed a 64% cell viability and the epoxide derivative showed a 72% 
cell viability (Fig 3.10.2). 
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. 3.4.8 The cytotoxic effects of AFBl and Zea on HepG2 cells 
It was decided to investigate the cytotoxicity of these two mycotoxins produced 
from two different toxigenic genera in an attempt to assess cytotoxicity levels as they co-
occur as reported in epidemiological studies. The dose response curve showed 100% cell 
viability at all concentrations of Zea while AFB 1 produced an increased cell viability with 
a decrease in AFBJ concentrations with 100% cell viabilities below 6.251lg/ml. However 
when both mycotoxins co-occur there is a distinct increase in cell mortality with increased 
toxin concentrations with the curve showing only 46.7% cell viability at 251lg/ml and 
100% cell viability at 1.561lg/ml (Fig. 3.11). 
From the results obtained it is clear that there were distinct differences between the 
cell lines in relation to their sensitivity to the mycotoxins and their derivatives. The 
statistical significance obtained using dose response curves and multiple box and whisker 
plots were effective in illustrating the varying cytotoxicity levels of the toxins. 
Concentrations of mycotoxins exhibiting higher absorbancy values than the controls may 
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AFB1 8,9 epoxide 
A multiple box and whisker plot showing the distribution of the toxicity 




Fig 3.6.2 A bar graph showing the cleavage activity of viable HepG2 cells as a 
measure of absorbancy following the exposure to AFBl and the AFB 1-


















Multiple box-and-whisker plot of 









8,9 epoxide AFB2 
A multiple box and whisker plot showing the distribution of the toxicity 
levels of AFB l -8,9-epoxide and AFB2 in HepG2 cells. 
Fig 3.7.2 
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A bar graph showing the cleavage activity of viable HepG2 cells following 
exposure to AFB l-8,9-epoxide and AFB2. Error bars represent standard 



















Multiple box-and-whisker plot of AFB1 
and its epoxide derivative in A549 cells 
AFB1 8,9 expoxide 
A multiple box and whisker plot showing the distribution of toxicity levels 
of AFBJ and AFB I -8,9-epoxide in A549 cells. 
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Fig 3.8.2 A bar graph showing the cleavage activity of viable A549 cells following 
the exposure to AFBI and AFBI-8,9-epoxide at various concentrations. 






















Multiple box-and-whisker plot of Zea 
and its epoxide derivative in HepG2 cells 
Zea epoxide 
A mUltiple box and whisker plot showing the distribution of the toxicity 
levels of Zea and the zea-epoxide in HepG2 cells. 
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Fig 3.9.2 A bar graph showing the cleavage activity of viable HepG2 cells as a 
measure of absorbancy levels following exposure to Zea and the zea-

























Multiple box-and-whisker plot of Zea 
and its epoxide derivative in Hela cells 
Zea epoxide 
A multiple box and whisker plot showing the distribution of toxicity levels 
of Zea and zea-epoxide in Hela cells. 
Fig 3.10.2 
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A bar graph showing the cleavage activity of viable he1a cells as a measure 
of absorbancy following exposure to Zea and the zea-epoxide. Error bars 
represent standard deviations, n=5. 
Fig 3.11 
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A bar graph showing the cleavage activity of viable HepG2 cells, as a 
measure of absorbancy following the exposure to AFB1, Zea and as they 
co-occur in the environment. Error bars represent standard deviations, n=5 . 
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3.5. DISCUSSION 
In most biological systems , a proper determination of the dose is difficult. This is 
also true for cell culture work. In fact the dose should be measured as the concentration 
of the test compound at the biochemical target, but in general this is not possible because 
we seldom know the exact target (Syversen, 1991). As in this investigation, the dose is 
represented as the amount of material added to the cell culture well. The cell culture 
medium may modify the behaviour of the compound in several ways. The single most 
important component in the medium is the serum which may cause a masking of toxicity 
(Syversen, 1991). Therefore increased FCS concentrations (10%) was used only during 
freezing of cells and its maintenance. During the cytotoxicity assays only 2% FCS was 
used. The high FCS concentrations is ideal for freezing because it does not crystallise and 
surrounds the cells preventing water from entering and crystallising the cells. 
Dimethysulfoxide is a dipolar, organic solvent which is also active in biological 
systems as a cryoprotective agent which protects the cells during freezing by minimising 
the formation of ice crystals which could be damaging to the cell. It also maintains the 
microsomal mono oxygenase activities in cultured hepatocytes which is important in the 
biotransformation processes in the liver cells (Villa et aI., 1991). In this investigation 
DMSO was also employed as a solubiliser of the mycotoxins during the preparation of the 
mycotoxin serial dilutions and the dark purple formazan crystals formed in the MTT assay. 
Alteration in cell morphology is a common effect of toxic substances on cells 
(Toivola and Eriksosson, 1991). Liver cells are affected by a great number of compounds 
acting by various subcellular mechanisms. Cell detachment would suggest a loss of 
viability, while the inhibition of cell growth suggests that mitosis of cells is in some way 
hindered by the toxin. Anchorage dependency is a characteristic feature of these cells 
(Evans, 1991). Cell division normally requires an appropriate substrate thus its 
detachment from the substrate would suggest an inhibition of mitosis and subsequent cell 
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growth. Cell rounding could be attributed to a loss of cell turgidity and the subsequent 
disruption of the cytoplasm. 
The twenty four exposure period proved too long a period for the cells. The toxin 
concentration was also very high resulting in a loss of cells. Their inability to cope with 
the toxic insult resulted in an inevitable loss of cell proliferation. Cells exposed to the 
toxins in the cytotoxicity assays also exhibited similar morphological alterations at high 
concentrations. Since the cytotoxicity testing was carried out in microtiter plates a 
number of variables were investigated such as varying concentrations and types of toxins. 
For the cytotoxic evaluation, the three different cell monolayers used in this study 
reacted differently to the toxins. The different cytotoxic effects elicited by the mycotoxins 
could be due to various factors and mechanisms which are not yet understood in detail. 
Main factors seem to be the ability of the mycotoxin to bind to cellular receptors and or 
penetrate cell membranes which is dependent on the size, structural conformation of the 
toxin molecule and the polarity of the compound (Thompson as cited by Hanelt et al., 
1994). The toxic modes of action of the mycotoxins studied is beyond the scope of this 
particular investigation but some limited conclusions have been drawn. One of the 
observations made is the variation in sensitivity of the cell lines to the toxins. The three 
most commonly encountered explanations for tissue to tissue variability in toxin sensitivity 
are tissue to tissue variability; in the amount of target enzymes or other cellular function 
which interacts with the toxin and in the amount of metabolic enzymes which activate a 
non toxic precursor molecule into a metabolite with non-specific toxicity and in the 
amount of detoxification mechanism that protects the tissue that are less susceptible to the 
toxic agent (Shier et al. ,1991). Each of these mechanisms may be abundant in certain 
differentiated cell types but present at low levels in all cell types; however these 
cytotoxicity evaluations do not distinguish between these mechanisms. 
Many have been investigating the metabolism in vitro of toxins by liver 
preparations from various experimental animals and humans to provide vital information in 
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order to elucidate the possible mechanisms responsible for speCIes differences In 
susceptibility to toxins. 
From the MTT assay important conclusions were drawn. HepG2 cells displayed 
an increased sensitivity to the AFB l-8,9-epoxide as compared to AFB 1, a difference which 
is significant in terms of toxicity. Such a result supports the extensive documented data on 
the biotransformation of AFBl into the AFB l-8,9-epoxide. It is well documented that the 
mechanism of toxicity of AFBl is mediated by the covalent binding of the AFBl-8,9-
epoxide, a chemically reactive metabolite, to cellular proteins and nucleic acids. It is this 
reaction of the electrophillic epoxide with various nucleophilic centres in cellular targets 
which is believed to be of critical importance in the carcinogenic process. The 
consequences of this "activation" reaction poses a biological hazard to the cell, exerting 
toxic, carcinogenic and genotoxic effects. 
Of the toxic actions associated with AFB 1 exposure, the most senous are 
mutagenicity and carcinogenicity which have been linked to the metabolic activation of the 
compound. As stated earlier P 450 is the principle enzyme system involved in the 
biotransformation of AFB 1. Independent of the tissue under investigation, activation of 
AFBl to the AFB l-8,9-epoxide is an absolute requirement for AFBl to manifest its 
mutagenic, carcinogenic and DNA binding actions (Massey, 1995). The results obtained 
for AFB2 cytotoxicity is of particular interest when one compares it with that of the 
AFB l-8,9-epoxide. It is known that the activation of AFB2 does not readily occur in rat 
species with its potency reduced by more than 150 times compared to that of AFBl 
(Roebuck et al., 1977). It has been shown in the duck liver that AFB2 is desaturated to 
form AFB1. The latter compound would then be available for activation through the 
epoxidation pathway (Roebuck et al., 1977). In these results it was shown that AFB2 
had no cytotoxic effect on the HepG2 cells which is in accordance with various previous 
studies (Roebuck et al., 1977). 
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Even though in most species the carcinogenic effects of AFB1 is expressed in the 
liver, the extreme toxicity and carcinogenecity of AFB1 (especially in the rat) suggests that 
in human exposure other organs may also be affected. AFB1 has been detected in human 
lung tumour tissue. It has been suggested that the respiratory system may be a target for 
the carcinogenic effects of AFBl, following inhalation (AFB1-laden grain dusts) and 
evidence supports suggestions that human lung is potentially at risk through aflatoxin 
exposure to the diet (Massey, 1995). In South East Asia it was reported that several 
individuals died following an acute exposure to aflatoxin. Reports showed that AFB 1-
DNA adducts were detected and measured by Hplc and immunochemically in lung tissue 
(Harrison and Garner, 1991). 
There is also a growing body of animal data implicating AFB 1 as a potential lung 
carcinogen. It was shown that whole rabbit lung microsomes were as active as liver 
microsomes in catalysing the formation of a DNA-binding metabolite of AFBl (Daniels, 
1990). Lung microsomes were however found to be more active than liver microsomes in 
the activation of AFBl when data were expressed in terms of microsomal P450 content 
(Daniels, 1990). It has been shown in this study that the A549 cells have the ability to 
rapidly biotransform AFBl into the AFB l-8,9-epoxide since the cytotoxic assay showed no 
significant difference between the toxicities of the parent toxin and its derivative. This can 
be supported by the fact that the lung cells contain an increased P 450 content as compared 
to the liver cells. 
The cytotoxic effect of Zea and its derivative on HepG2 cells showed a significant 
difference between the toxicities but the dose response curves were similar. An increased 
toxin concentration was associated with an increased cell death. It is generally accepted 
that the liver is one of the target organs for oestrogen (Nagasue et ai. , 1986). As already 
stated Zea mimics oestrogen. The discovery of oestrogen receptors in the cytosol of 
hepatocytes has stimulated research attempting to define a possible role for steroid 
hormones, particularly oestrogens in the pathogenesis of hepatic disorders. Eagon et al. 
(1991) have suggested that certain liver diseases may be unusually oestrogen responsive. 
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Adenoma and hepatoma are disorders which have been associated with the use of steroidal 
agents such as oestrogen. It has further been postulated that a decreased content of 
cytosolic oestrogen receptors is linked to increased hepatocyte proliferation (Francavilla et 
' aLi1984) , As seen in the dose response curve the high doses of Zea and its epoxide 
administered to HepG2 cells caused a regression of hepatoma cell proliferation while 
lower doses enhanced cell proliferation, It has been shown that small doses of oestrone 
and 17~ estradiol promotes cell proliferation while higher doses have the opposite effects 
(Mishkin et al. , 1983). Neuer et al (1994) showed that Zea stimulated the production of 
prostacyclin (has vasodilatory and antiaggregatory properties) in endothelial cells cultures 
from human umbilical cords production at low concen~rations (10-7 M) and inhibited it at 
higher concentrations (10-5 M), 
However in Hela cells both Zea and its derivative greatly enhance cell proliferation 
at high doses, The observed signs of hyperoestrogenism in reproductive studies have 
prompted a number of investigators to examine the interaction of the resorcylic acid 
lactones at the oestrogen target tissue level in order to determine how closely these 
compounds in fact mimic the actions of the endogenous oestrogens at these sites 
(Goodman et al., 1987). From the results obtained it appears that both Zea and the 
epoxide elicit similar cell proliferative effects which suggests that both compounds initiate 
a sequence of events that follow oestrogenic stimulation. The results obtained are in 
accordance with various documented evidence that shows an increase in uterine weight 
and protein content. They have suggested that Zea and its metabolites form a receptor 
complex which translocates to the nucleus in a manner analogous to the estradiol receptor 
complex and enhances cellular proliferation as observed in this result. 
There has been increased recognition that several species of toxigenic fungi can 
contaminate crops through the production system. Research has further led to the 
conclusion that toxigenic fungi typically make metabolites which would suggest that food 
containing a particular mycotoxin such as aflatoxin can and usually does contain other 
mycotoxins. Widiastuti et al. (1988)(a) showed the presence of aflatoxins and Zea in 
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samples of Indonesian corn analysed. Another interesting study showed the presence of 
cyclopiazonic acid in combination with aflatoxins, Zea and ochratoxin A in Indonesian 
corn (Widiastuti, 1988) (b). The possibility of synergistic toxicity is very real. It has been 
well recognised that naturally contaminated grain can be more toxic than the known, pure 
mycotoxins (Miller, 1993). The co-occurence of Zea and aflatoxins has been reported in 
Brazil and Indonesia. It was therefore necessary to evaluate the toxicities of these 
mycotoxins as they co-occur in nature. From the results obtained it is clear that the effects 
of pure Zea are antagonised by the presence of pure AFBI at the higher concentrations and 
is enhanced at lower concentrations. 
3.6. CONCLUSION 
The MTT assay proved to be a reliable and reproducible technique in assessing the 
cytotoxicity of these mycotoxins and their derivatives. As documented previously AFBl 
requires metabolic activation via epoxidation to exert its biological activities and express 
its toxic properties. The use of different cell lines was effective in illustrating the specific 
sites of action of these mycotoxins as was clearly shown by the varying degrees of 
toxicities expressed by Zea and AFB 1 in the different cell lines used in this investigation. 
Chapter 4 
A COMPARISON OF THE ULTRASTRUCTURAL EFFECTS OF 
AFBl AND THE AFBl-8,9-EPOXIDE ON HepG2 CELLS 
4.1 INTRODUCTION 
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Microscopy has proven to be an invaluable tool during this "mycotoxin gold rush 
era" in understanding the mechanisms of action of some mycotoxins such as AFB l. 
Various researchers have explored the use of microscopy in both human ( cell lines) and 
animal models (biopsies) exposed to AFB1. To date, many have concluded that 
morphological and biochemical lesions caused by the acute administration of AFBI to 
animals appears almost exclusively in liver and persist for variable lengths of time, 
depending upon the dose levels and other parameters (Pong and Wogan, 1970). In this 
particular investigation microscopy has been utilised to determine the sequence and 
progression of morphological changes observed in mycotoxin treated human hepatoma 
cells. 
The liver has been studied as a model system for many aspects of both normal and 
abnormal morphology, biochemistry and cell biology. These studies have reflected both 
the abundant availability of tissue and wide range of hepatic structure and functions. Data 
" 
on the interactions of carcinogens with macromolecules in mammalian systems has been 
obtained from the liver using varying doses of the carcinogen which result in acute injury 
rather than neoplasms. Extensive work on the effects of AFBl on rat liver ultrastructure 
has been documented since it was discovered that the liver is almost exclusively the organ 
of attack (Scaife, 1971). However, cells from other tissue can be affected but may 
require higher concentrations or longer exposure periods to achieve the same results. 
Work done on the effects of AFB J at a light microscopic level in Hela and human lung 
cells showed that AFBJ elicits many toxic responses (Legator, 1966). The earliest 
observed effects of the toxicant was the suppression of DNA synthesis and the formation 
of giant cells which suggests that specific organelles are being targeted by the toxin 
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(Legator, 1966). This seems likely as the effects of many toxic agents on cells which are 
mediated via damage to one or more of these specialised subcellular compartments. 
Specific organelle systems may become damaged by the toxic agent when the organelle 
begins to play a primary role in the metabolism of a particular toxicant , when a toxic ant is 
stored intracellularly, or as a result of an inherent sensitivity of some essential biochemical 
pathway in the organelle to perturbation (Fowler et aL, 1989). As organelle 
compartments play crucial roles in facilitating metabolic processes, their alteration due to 
the effects of a toxicant may hinder cell growth and decrease cellular viability (Fowler et 
al., 1989). 
Many investigators in the field of mycotoxicology have used light and transmission 
electron microscopy (rEM) to assess the effects of toxins on rat hepatoma cells 
(Svoboda, and Higginson, 1968). Their work revealed invaluable information about the 
toxic properties of AFB1, particularly its effects on the nucleus. The TEM results 
obtained showed that AFBl interferes with DNA synthesis in hepatoma cells of rats fed 
AFB1-contaminated feed by altering the structure of the nucleolus (Svoboda and 
Higginson, 1968). It was therefore pertinent to examine the cellular alterations in human 
hepatoma cells exposed to AFBl , AFBl -8,9-epoxide and AFB2 using TEM and light 
microscopy in an attempt to correlate these alterations with biochemical events associated 
with cell death. 
To confirm the presence of antigens in altered organelles many researchers have 
used antibodies to detect cellular antigens thus expanding our knowledge of both internal 
structure and the classification of cells (Goers, 1993). In immunocytochemical staining of 
cells, antibodies bind to surface or intracellular antigens and are then detected by one of 
many labels such as enzymes; isotopes or colloidal gold. Cells suitably fixed to preserve 
morphology can be visualised by either electron or light microscopy to localise antigens. 
Since the introduction of immunocytochemistry (ICC) into biological research, a 
tremendous amount of research with often spectacular data have appeared (Leeuwen, 
1982 as cited by Aggenbach,1986). These ICC staining methods take advantage of the 
extraordinary specificity of immune reactions to identify antigens in tissue (Snyman, 
1988). In the present study, ICC has been employed in the identification and localisation 
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of AFBl its AFBl 8,9-epoxide derivative and AFB2 using a polyclonal AFBl antibody. 
The advantage of using polyclonal antibodies for ICC is that they contain a population of 
antibodies which can recognise many epitopes on the antigen (Snyman, 1988). Tissue 
sections are exposed to the primary antibody (anti-AFB 1) and is then visualised by a 
labelled secondary antibody (goat anti-rabbit IgG gold probe). This gold probe is a gold 
sphere of 5 to 10nm. In addition, confocallaser scanning microscopy (CLSM) was used 
to complement ICC, since there are pitfalls to the use of ICC. Such pitfalls include the 
loss of label following post embedding techniques due to the masking of the antigen 
during tissue processing and embedding (Snyman, 1988). 
Confocallaser scanning microscopy is a new optical microscopic technique, which 
offers significant advantages over conventional microscopy. Light which is emitted from 
regions other than the focal plane, is cut off by introducing a diaphragm in the beam path 
(Fink-Puches et al., 1995). The result is an optical "slice" which shows more detail 
because the blurring from out of focus haze disappears. Researchers have begun to use 
CLSM in conjunction with immunofluorescence and fluorescent in situ hybridisation in an 
attempt to trace biological compartments within cells and tissue (Messerli and Perriard, 
1995). Another advantage of CLSM is the computerised rendering of digital images 
which permits image processing such as contrast stretching, pseudo-colour presentations 
and morphological analyses, using software packages (Ockleford, 1995). It allows one 
to examine surface morphology by viewing the phase contrast image and visualising the 
fluorochrome labelled antigen. Superimposition of the labelled area on the phase contrast 
image enables one to localise the florescent label (toxin) within the cell . The confocal 
technique has been employed in this study to detect the presence of AFBl based on its 
fluorescent properties at a wavelength of 45011 (Wogan, 1966). The CLSM offers the 
best approach to non destructive high resolution examination offeatures of living cells. 
The cell surface also provides valuable information in understanding the condition 
of the cell following exposure to a toxic treatment. The scanning electron microscope 
surpasses other instruments for viewing cell surface morphology, provides a 3D image of 
the surface and magnifies images up to 20,000x (Wolosewick and Parker, 1979). The 
illuminating system of the SEM is similar to that of the conventional TEM, however the 
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electron beam is focused by one or more condenser lenses into a narrower pencil of the 
electron beam, which scans the surface of the specimen. As the beam strikes the surface 
of the specimen high energy backscattered and low energy secondary electrons are given 
off. The signal is picked up, amplified and displayed on the cathode ray tube. In this way 
a picture is built on the screen which corresponds point by point to the surface contours of 
the area of the specimen which is being scattered by the beam. A record of the image is 
made by photographing the image on the screen with a camera (Carr and Toner, 1982). 
The following chapter aims to correlate the results obtained using the various 
microscopic techniques mentioned above in an attempt to determine the mechanisms of 
action of the selected mycotoxins and its effects on cellular metabolism. 
4.2 MATERIALS AND METHODS 
a) Light microscopy 
HepG2 cells were grown (37°C for 48 hours) on sterile Chance glass coverslips 
(Boehringer Mannheim) until confluent (Robinson, 1982). Cells on one coverslip were 
treated with AFBl (12I1g/ml) for 24 hours while a second coverslip of cells were treated 
with the AFB l-8,9-epoxide (1211g/ml) for 24 hours. Adherent treated and untreated cells 
were rinsed in pre-warmed (37°C) HBSS, fixed in 1.5% gluteraldehyde for ten minutes, 
rinsed in HBSS for two minutes and then rinsed thoroughly in distilled water before 
staining with Mayer's haemotoxylin and eosin (5%) (Drury and Wallington, 1980). 
b) Transmission electron microscopy (TEM) 
HepG2 cells were grown in culture flasks (25cm3) until confluent. Flasks were 
then exposed to AFBl, AFBl-8,9-epoxide and AFB2 at 1211g/ml for 24 hours. Following 
this exposure period both untreated and treated cells were fixed, dehydrated and 
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embedded in situ. Blocks from the flasks were sectioned with the cells sandwiched 
between the resin and the plastic (Robinson and Gregory, 1977). Sections were cut on the 
Reichert Ultracut microtome. Thick sections (lllm) were stained with 1% toluedene blue 
(Drury and Wallington, 1980) in a 50:50 distilled water:acetone solution containing 10% 
borax.U1trathin sections mounted on 200 mesh copper grids were stained with uranyl 
acetate followed by Reynold's (1963) lead citrate. Sections were viewed with a Joel lOB 
transmission electron microscope (60kV) in the Physiology Department of the University 
of Natal and a lOOS Joel Electron microscope in the Electron microscope unit at the 
University of Natal. The processmg schedule of the various steps in TEM are 
summarised in the following table. 
Table 9 The processing schedule for TEM 
Step Solution Time 
1. Fixation 1 hour (25°C) 
Cells are fixed in 1 % gluteraldehyde in Hanks 
Balanced salt solution (HBSS) 
2. Buffer rinse 
Rinse in HBSS 
3. Post fixation 1 hour (4°C) 
Post fix in 1% osmium tetroxide 
4. Buffer rinse 10 min 
Rinse in HBSS (x2) 
5. Dehydration- 70% ethanol 20min 
6. Dehydration- 90% ethanol 20min 
7. Dehydration- 100% ethanol 30 min 
8. Dehydration- 100% ethanol 30 min 
9. Ethanol:Araldite 50:50 30 min 
10. Araldite 1 hour (60°C) 
11. Araldite 48 hours (60°C) 
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c) Immunocytochemistry 
For ICC, a post-embedding technique was employed (Snyman, 1988), where the 
immunolabelling was carried out on sections of AFBl , AFBl-8,9-epoxide and AFB2 
treated cells picked up on nickle grids. The primary antibody used was a rabbit polyclonal 
anti-AFB1 (1: 100) (Sigma) and the secondary antibody used was a goat-anti-rabbit IgG 
gold conjugate (10nm). Grids were treated with hydrogen peroxide (5%) and normal goat 
serum to block non-specific binding sites. The primary antibody used was a polyclonal 
(rabbit anti-AFB 1 ) (1: 100 ), while the secondary antibody was goat anti rabbit IgG 
conjugated to a 5 to 10nm gold probe. Sections were viewed using a JEOL-JEM lOOS 
transmission electron microscope. 
Method controls 
The method specificity may be defined as the absence of staining caused by 
mechanisms other than the immunological interactions between primary antibodies and the 
antigen to be localised (Leeuwen, 1986). It involves the omission of either the primary 
antiserum or the secondary layer antibody or the immunogold step for immunolabelling. 
In this study the method control excluded the primary antibody. These method controls 
serve to exclude the non immunological interactions between the secondary antibody and 
the detection system. 
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Table 10 The staining procedure using Immuno-Gold on resin sections for TEM 
Procedure Time 
1. Etch non-osmicated sections on nickle grids by 3 min 
placing on a droplet of 5% hydrogen peroxide 
2. Place grids on a drop of distilled water then jet 
wash with 10ml distilled water and dry 
3. Submerge grids at room temperature in normal 30 min 
goat serum -diluted 1:20 
4. Drain on fibre free paper 
5. Droplet of primary antiserum and one method 3 hours 
control in PBS or normal goat serum 
6. Droplet of 50mM Tris pH 7.2 Thenjet wash 
with 20ml /grid 
7. Droplet of 50mM Tris containing 0.2% bovine 
serum albumin (BSA) pH 7.2. Then jet wash in 
5ml/grid 
8. Droplet of 50mM Tris containing 1% BSA pH 8.2 5 min 
9. Droplet of IgG-gold diluted 1: 15 in Tris/BSA 1 hour 
pH8.2 
10. Droplet and jet wash as before using: 
lOml/grid 50mM Tris containing 0.2% BSA pH 
7.2 
5ml/grid 50mM Tris pH7.2 
5ml/grid distilled water 
11. Counterstain with 2% uranyl acetate 
Jet wash with distilled water 
Counterstain with Reynolds lead citrate 
Jet wash with distilled water 
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d) Confocal microscopy 
RepG2 cells were grown on glass coverslips (as described previously) until 
confluency was attained. The confluent cells, were then incubated with AFBl 12llg/ml) 
for varying time intervals (4 hours; 8 hours; 12 hours; 24hours). After incubation, the 
cells were washed in HBSS(twice), fixed in 1% gluteraldehyde solution (Sml) (1S 
minutes), rinsed with HBSS (Sml), placed on glass slides and sealed with glycerol (2ml). 
Finally, the cells were viewed on a True Confocal Scanner-Leica TCS 4D microscope 
(AFBl fluoresces under ultra violet light at 32Snm). 
e) Scanning electron microscopy(SEM) 
Cells grown to confluency on pre-treated coverslips (as described previously) were 
prepared for SEM. Cells were rinsed in HBSS (Sml), fixed in 1% gluteraldehyde (Sml) in 
HBSS for 30 minutes at room temperature, rinsed, dehydrated through ascending grades 
of alcohol (Sml) and critical point dried using a specially designed holder (Evers et al., 
1983) in a Hitachi RCP I dryer. Cultured mammalian cells are amongst the most difficult 
specimens to p,repare for SEM. Being bound only by a cell membrane, not having the 
mechanical support afforded by cells in bulk tissue and often possessing long, fragile 
cytoplasmic processes renders this type of specimen extremely susceptible to various 
external disturbances (Evers et al., 1983). It is fortunate that a special holder designed to 
carry cell cultures through critical point drying was made available during this study to 
minimise accidental surface tension effects during processing and reduce debris (Evers et 
aI., 1983). Five two minute purges were used over a period of one hour and the critical 
temperature of 4SoC for five minutes. Venting after drying was completed after 10 
minutes and the overall time in the dryer was at least 7S minutes. Dried coverslips were 
attached on stubs using silver paint, cells coated with 60:40 gold:palladium from a 
distance of 10cm in a gel JEE 4 vacuum evaporator. 
Table 11 Processing for SEM 
Step Processes Time 
1. Fixative- 1 % gluteraldehyde 20 min 
2. ButTer rinse - HBSS (25°C) 5 min 
3. Post fixation - Osmium 20 min 
tetroxide(0.5%) 
4. Rinse- distilled water 
5. Dehydration- 30% ethanol 10 min 
6. Dehydration- 50% ethanol 10 min 
7. Dehydration- 70% ethanol 10 min 
, 
8. Dehydration- 90% ethanol 10 min 
9. Dehydration- 100% ethanol 10 min 
10. Critical point drying +/- 90 min 
11. Sputter coating-60:40 Palladium: 10 min 
silver 
The coverslips were viewed using a S 520 SEM with the following settings: 
Accelerating voltages of 10 to 25 k V 
Beam current of 20nA ° 





a) Light microscopy 
In the untreated HepG2 cells, nucleoli were characteristically large and contained 
single or multiple prominent nucleoli of irregular shape (Fig 4.1). Cells treated with AFB 1 
and the 8,9 epoxide (12llglml) showed similar morphological alterations. These included 
microvesicular steatosis (Fig 4.2), the presence of multinucleated cells (Fig 4.3), 
micro segregation of nucleoli (Fig 4.4), cytoplasmic blebbing (Fig 4.5), increased 
cytoplasmic vacoulation (Fig 4.6) and increased numbers of mitotic figures and abnonnal 
mitoses (Fig 4.7). 
b) Transmission electron Microscopy 
Cultured liver cells (HepG2) treated with the AFBl and AFB l-8,9-epoxide showed 
marked cellular alterations (Table 12). The TEM results showed cytoplasmic and 
nuclear alterations in AFBl and AFBl -8,9-epoxide treated cells while untreated cells 
showed numerous, ovoid mitochondria (Fig. 4.8) and organelle structures (Fig 4.9) which 
are characteristic features of hepatoma cells (Trump, 1965). In addition the organelles 
most effected by both AFBl and the AFB l -8,9 epoxide treatments were the mitochondria, 
endoplasmic reticulum (ER) and nucleolus. 
The AFBl treated cells showed fewer mitochondria with occasional elongated and 
swollen forms (Fig. 4.10). AFB l-8,9-epoxide treated cells, however, showed fewer 
mitochondria with many appearing larger and distorted (Fig 4.11) with a loss of 
membrane integrity and subsequent clearing of the mitochondrial matrix (Fig. 4.12). 
Another mitochondrial alteration observed in AFBl-8,9-epoxide treated cells was the 
presence of cristae arranged in a parallel, whorled or oblique orientation (Fig 4.13). AFB2 
treated cells showed no change in mitochondrial ultrastructure with the mitochondria 
remaining structurally intact (Fig 4.14). 
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Swollen ER were occasionally observed, often in close proximity to the 
mitochondria in AFBl (Fig 4.15) and AFB l-8,9-epoxide treated cells. However, the 
increase in swelling of ER was more pronounced in epoxide treated cells and in addition 
was filled with proteinacious material (Fig 4 .16). Swelling of ER was also associated with 
a loss of ribosomes. Areas of cytoplasmic lysis was another feature frequently observed 
in treated cells but were more pronounced in AFBl (Fig 4.17) treated cells as compared to 
AFB l -8,9-epoxide treated cells (Fig 4.18). 
Numerous secondary lysosomes and myelin figures were present in AFBl treated 
cells (Fig 4.19). No myelin figures were observed in AFBl-8,9-epoxide treated cells as 
compared to AFBl treated cells but large secondary lysosomes were present (Fig 4.20) 
which may be indicative of more rapid degenerating organelles. In both controls (Fig 
4.21) and AFBl treated cells (Fig 4.22) cytoplasmic blebbing was displayed by several 
cells but blebs appeared more swollen (Fig 4.23) and grossly altered in the AFBl-8,9-
epoxide treated cells (Fig 4 .24). Areas of cytoplasmic lysis were often present in the blebs 
and were pronounced in AFB 1-8, 9-epoxide treated cells. The presence of swollen golgi 
was only observed in epoxide treated cells (Fig 4. 25). 
Nuclear alterations in AFB 1 treated cells included the presence of large prominent 
nucleoli (Fig 4 .26) nucleolar macro segregation and chromatin clumping at the periphery of 
the nucleus (Fig 4.27). The fibrillar and granular components of the nucleolus appeared 
as distinct light and dark zones (Fig 4.28). The untreated cells showed a distinct 
nucleolus (Fig 4.29) with the fibrous and granular components being indistinguishable. 
Epoxide treated cells showed an abundance of euchromatin and a single large nucleolus 
fibrillar and granular components being distinguishable (Fig 4.30). 
In contrast to AFBl and AFB l-8,9 epoxide treated cells, AFB2 showed no cellular 
alterations. The nucleolus was centrally situated and structurally intact.(Fig 4.31). 
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Table 12 A comparison of ultrastructural alterations of AFBl and AFBl-8,9-
epoxide treated cells 
AFBl AFBl-8,9- epoxide 
Nucleus 
Hetero and euchromatin Abundant euchromatin 
Large nucleoli - more than one Single large nucleolus 
micro segregation 
Many karyosomes Occasional karyosomes 
Irregular and invaginating nuclear Nuclear membrane is regular 
membranes in a few cells. 
Mitochondria 
Numerous Few 
Slight alteration in the orientation in the Swollen, larger and distorted. Cristae 
cristae appeared parallel, whorled and oblique. 
Cristae were inconspicuous in many. 
Occasional elongated forms Occasional elongated forms. 
A fair number of myelin figures No myelin figures observed but numerous 
vacuoles present. 
Mitochondrial membrane integrity Loss of membrane integrity with clearing of 
maintained mitochondrial matrix 
Numerous areas of cytoplasmic lysis with Not as pronounced 
smaller and larger pockets. 
Few swollen cisternae of rough Many swollen cisternae of endoplasmic 
endoplasmic reticulum reticulum. Some filled with proteinacious 
material 
Numerous secondary lysosomes Numerous secondary Iysosomes 
Some cytoplasmic processes showed areas Numerous cytoplasmic processes with 
of !ysis. areas of lysis 
Normal golgi-several golgi bodies Swollen 
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c) Immunocytochemistry 
Table 13 Intensity of label in organelles treated with the various toxin treatments 
Altered organelles AFBl treated AFBl-8,9- epoxide AFBz 
Nucleolus + ++ -
Mitochondria + ++ -
Endoplasmic ++ + -
reticulum 
Cytoplasmic blebs + ++ -
Cytoplasm ++ ++ -
Adjacent to the cell ++ ++ -
absence oflabel 
+ presence of a few gold probes 
++ presence of several probes 
The ICC confirmed the presence of gold labelled anti-AFB 1 in both AFB1and 
AFBl-8,9 epoxide treated cells. However label was not found in AFB2 treated cells. Cells 
exposed to AFBl and the AFB l-8,9-epoxide showed the presence of label in close 
proximity to the mitochondria and within the swollen ER (Fig 4.32). Label was often 
found in the cytoplasmic blebs and in close proximity to them (Fig 4.33). Label was 
present at the periphery and in the centre of the nucleus (Fig 4.34) in AFBl and AFB l -8,9-
epoxide treated cells (Fig 4.35). Cultured liver cells treated with AFB2 showed no label 
using the polyclonal anti-AFBl. In AFBl treated cells label was found in areas of 
cytoplasmic lysis (Fig 4.36), along the cell membrane (Fig 4.37) and in vesicles (Fig 4.38). 
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d) Confocal Microscopy 
Confocal microscopy results showed that in the four hour treated cells AFBl was 
localised in the nucleolus (Fig 4.39); in the 8 hour treatment the toxin spread throughout 
the nucleus (Fig 4.40); in the 12 hour treated cells the toxin spread throughout the nucleus 
(Fig 4.41); and the 24 hour treated cells showed toxin distributed throughout the 
cytoplasm (Fig 4.42). During the 24 hour exposure period many cells were dead showing 
a high fluorescence of toxin. 
e) Scanning electron microscopy 
Untreated cells were attached to the substrate (Fig 4.43) with the surfaces of the 
cells being covered by long filamentous cytoplasmic processes [(Fig 4.44), (Fig 4.45), Fig 
4.46) ]. Both AFBl and AFBl-8,9-epoxide treated cells displayed high cell mortality rates 
and alterations of cytoplasmic processes. Cell rounding, indicative of cell death was 
frequent in treated cells (Fig 4.47). Cytoplasmic processes in treated cells appeared 
shorter and rounded (Fig 4.48). 
Fig 4.1 A light micrograph showing untreated HepG2 cells with large and prominent nucleoli (N) 
(x4000). 
Fig 4.2 HepG2 cells treated with AFBJ showing microvesicular steatosis (Mv) (x4000). 
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Fig 4.3 AFBI treated cells showing the presence of multi nucleation (Ml) (x4000). 
Fig 4.4 AFBI treated cells showing the microsegregation (Ms) of nucleoli (x4000). 
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Fig 4.5 AFBj treated cells showing cytoplasmic blebs (Cb) (x4500). 
Fig 4.6 AFBj treated cells showing increased cytoplasmic vacoulation (v) (x4000). 
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Fig 4.7 AFB\ treated cells showing abnormal mitoses (AM) (x4000). 
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Fig 4.8 Electron micrograph of untreated HepG2 cells showing numerous ovoid mitochondria (M) which 
are characteristic of hepatoma cells and a few cytoplasmic blebs (Cb). The cells are sandwiched 
between the flask (FI) and the resin (R). 
Fig 4.9 Electron micrograph of an untreated HepG2 cell showing intact organe1Ies such as ovoid 
mitochondria(M), rough endoplasmic reticulum (rER), golgi (G), and secondary lysosomes (L) 
Fig 4.10 Electron micrograph of a AFB1 treated cell showing fewer mitochondria than controls with 
occasional elongated forms (M) close to the nucleus (NL). 
Fig 4.11 Electron micrograph of a AFB1 -8,9-epoxide treated HepG2 cells showing larger, distorted 
mitochondria with a loss of membrane integrity(M). 
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Fig 4.12 Electron micrograph of a AFB\ -8,9-epoxide treated cell showing clearing of the mitochondrial 
matrix (m) and the presence of cytoplasmic blebs (Cb). 
Fig 4.13 Electron micrograph of a AFB\-8, 9-epoxide treated cell showing disorientation of cristae (c) and 
cytoplasmic blebs (Cb). 
Fig 4.14 Electron micrograph of a AFB2 treated cell showing the presence of intact mitochondria (M) 
Flask (Fl), resin (R) . 
Fig 4.15 Electron micrograph of an AFBJ treated cell showing the presence of slightly swollen rER in 
close proximity to the mitochondria (M). Areas of cytoplasmic lysis are visible together 
with secondary lysosomes CL) 
104 
105 
Fig 4.16 Electron micrograph of an AFB] -8,9-epoxide treated cell showing grossly swollen endoplasmic 
reticulum (ER). 
Fig 4.17 Electron micrograph showing areas of cytoplasmic lysis (Cl) observed in AFB] treated cells 
together with focal areas of lysis in cytoplasmic blebs (Cb). 
Fig 4.l8 Electron micrograph showing areas of cytoplasmic lysis(CI) observed in AFB)-8,9-epoxide 
treated cells and within the cytoplasmic blebs (cb). Mitochondria (M). 
Fig 4.19 Electron micrograph showing the presence of numerous secondary lysosomes (L) and 
cytoplasmic blebs (cb) in AFB) treated cells. 
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Fig 4.20 Electron micrograph showing a few secondary lysosomes (L) filled with proteinacious material, 
probably degenerate organelles in AFBJ -8,9-epoxide treated cells. Cytoplasmic blebs (cb), 
Flask (FI). 
Fig 4.21 Electron micrograph of an untreated HepG2 cell showing the presence of a prominent nucleus 
(NL), numerous ovoid mitochondria (M) and cytoplasmic blebs (cb). Flask (FI). 
Fig 4.22 Electron micrograph showing cytoplasmic blebbing (cb) in AFB] treated cells. 
Fig 4.23 Electron micrograph of cytoplasmic blebs (cb) and slightly swollen golgi (G) in AFB]-8,9-
epoxide treated cells 
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Fig 4.24 Electron micrograph of grossly altered cytoplasmic blebs (Cb) in AFBj-8,9-epoxide treated 
cells. 
Fig 4.25 Electron micrograph showing the presence of grossly swollen golgi observed in AFBj-8, 9-
epoxide treated cells and slightly swollen rER. 
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Fig 4.26 Electron micrograph of a AFB1-treated cell showing the presence of a large nucleolus (N), a 
few secondary lysosomes (L) and cytoplasmic blebs (cb). 
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Fig 4.27 Electron micrograph of a AFBl treated cell showing microsegregation of the nucleoli (N), 
chromatin clumping (cc) along the periphery of the nucleus, and areas of cytoplasmic lysis (Cl). 
Flask (Fl), resin (R). 
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Fig 4.28 Electron micrograph showing the presence of distinct fibrillar (f) and granular (g) components 
of the nucleolus of AFB] treated cells which is indicative of an inhibition of DNA dependent 
RNA synthesis. Nucleus (NL), secondary lysosomes (L). 
Fig 4.29 Electron micrograph showing the presence of a distinct nucleolus (N) in untreated HepG2 cells 
with no differentiation. 
Fig 4.30 Electron micrograph showing the presence of a large nucleolus (N) and a few fibrous centers 
(fc) in AFBI -8,9-epoxide treated cells. 
Fig 4.31 Electron micrograph of an AFB2 treated cell showing the presence of normal looking nuclei 
(NL) with a distinct nucleolus (N). 
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Fig 4.32 An immunocytochemical (ICe) electron micrograph showing the presence of polyclonal 
gold labelled anti-AFB1 in the swollen rER and in close proximity to it in a AFBl-8,9-epoxide 
treated cell .Label is encircled. 
Fig 4.33 ICC electron micrograph showing the presence of lOnm gold probes within the cytoplasmic bleb 
(cb) and in the nucleoplasm (Np) of a AFBl-8,9-epoxide treated cell. 
Fig 4.34 ICC electron micrograph showing the presence oflabel in the nucleoplasm (Np) in an AFBJ 
treated cell. 
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Fig 4.35 ICC electron micrograph showing the presence oflabel in the nucleoplasm (Np) and within the 
nucleolus (N) in AFBJ -8.9-epoxide treated cells. 
Fig 4.36 ICC electron micrograph showing the presence of label in areas of cytoplasmic lysis (Cl) of 
AFB\ treated cells. 
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Fig 4.37 ICC electron micrograph showing the presence oflabel along the cell membrane(cm)of an 
AFB\ treated cell. 
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Fig 4.38 ICC electron micrograph showing the presence of label close to vesicles (v) in AFBJ treated 
cells. 
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Fig 4.39 Confocal micrograph showing the localisation offlourescent AFBJ (l2Ilglml) in the nucleolus 
(N) after a four hour incubation period. The toxin is represented by the pink stain. The greater 
the intensity of the colour the greater the amount of toxin. 
117 
Fig 4.40 Confocal micrograph showing the presence offlourescent label (AFB]) in the rest of the nucleus 
after 8 hours. 
Fig 4.41 Confocal micrograph showing the presence of fluorescent label within the cytoplasm (C)after 12 
hours. 
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Fig 4.42 Confocal micrograph showing the label after 24 hours which spread throughout the cell. 
Fig 4.43 A scanning electron micrograph showing the cell surface processes of untreated HepG2 cells (C). 
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Fig 4.44 Scanning electron micrograph of the filamentous processes of untreated cells (f) which allow the 
cells(C) to attach to the substrate and to one another. 
Fig 4.45 Scanning electron micrograph of a confluent layer of untreated cells at a higher magnification 
as they lie next to one another (C). The filamentous processes (f) are interconnected. in untreated 
cells. 
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Fig 4.46 Scanning electron micrograph showing the interconnecting projections (p) of untreated cells (C). 
Fig 4.47 Scanning electron micrograph of AFBl treated cells which appeared rounded (cr), indicative of 
cell death and together with cellular debris (cd). 
Fig 4.48 Scanning electron micrograph of a AFBJ treated cell showing the presence of rounded 





The use of cultured cancerous cell lines for electron microscopy has proven to be 
invaluable in the correlation of internal architecture to the environmental stress. The use 
of the HepG2 cell line in this investigation is attributed to its high rate of turnover and is 
representative of the target organ of the toxic insults. Many of the cellular alterations 
observed in toxin treated cells may be manifestations of cell injury. AFBl has been 
characterised as an indirect hepatotoxin that produces injury by interference with a specific 
metabolic pathway or process essential for cell integrity (Zimmerman and Ishak, 1987). 
As compared to the untreated cells, both AFBl and AFBl-8,9- epoxide treated 
cells displayed similar cellular alterations at the light microscopic level (Fig 4.1 to 4.7) 
which could be attributed to the extreme toxicity of these mycotoxins, which caused a 
rapid cell death and the subsequent detachment from the substrate. It is possible that 
because of the extreme toxicity of the AFBl-8,9-epoxide (after a 24 hour incubation 
period), most of the cells died and detached from the substrate leaving only a few behind 
while the AFB 1 treated cells were not as severely affected by the toxin, thus remaining 
firmly attached to the subtrate, displaying only slight cellular alterations at the light 
microscopic level. Cytoplasmic processes which are essential in cell anchorage on the 
substrate were shown by SEM to be altered. Cells that detach from the substrate have 
rounded processes while cells attached to the surface have numerous long filamentous 
processes attached to both the cell surface and to one another. The attachment of cells to 
each other and to the culture substrate is mediated by cell surface glycoproteins and Ca2+ 
and Mg2+ ions. The loss of cell viability would imply a loss of production of these ions 
and glycoproteins required to facilitate cell adhesion (Freshney, 1983). 
Lipid accumulation within the liver cells exposed to both AFBl and the AFB l-8,9-
epoxide as observed by light microscopy may be related to reduced protein synthesis and 
the subsequent impaired release of lipid as lipoprotein (Zimmerman and Ishak, 1987). It 
is possible that AFBl blocks the synthesis of proteins by binding to ribosomes and 
therefore prevents the mobilisation of fatty acid metabolism. The defective egress of lipid 
from the liver is defined as hepatic steatosis which occurs as a result of the defective 
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synthesis of the apoprotein moiety of the very low density lipoprotein (VLDL) needed to 
transport the lipid from the liver to the depots (Zimmerman and Ishak, 1987). 
Microvesicular steatosis observed in AFBl and AFB l-8,9-epxoide treated cells 
would suggest that these toxic insults attribute to the accumulation of lipid within the . cell. 
It has been previously documented that there does exist a possible relationship between 
AFBl and fatty degeneration in Thai children (Bourgeois et a!., 1971). It was found that 
Reye' s syndrome, a childhood neurologic disease consisted of systems including a pale 
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fatty liver. Evidence from Thailand associated the high levels of AFBl in victims tissues 
with Reye's syndrome (Bourgeois et a!., 1971). 
The presence of multinucleated cells in toxin treated groups may be attributed to 
its inability to undergo mitosis whilst still undergoing meiosis and is therefore implicated in 
decreased cell growth (Grossfield et al., 1963). Legator (1965) showed that AFBl 
suppressed mitosis and DNA synthesis leading to an increase in giant cell formation and 
cell vacuolisation. Abnormal. mitoses was also a feature observed only in toxin treated 
cells. Although it is known to be a common feature of cancerous cells, it was not 
observed in the untreated cells and therefore it can be postulated that the toxins induce 
DNA mutations. 
The altered structural state of the mitochondria may be attributed to the toxin 
treatment. Previous studies show that mitochondria are one of the major cellular targets 
for AFBl during experimental carcinogenesis. It is documented that the c P-450 type of 
mono oxygenase system in rat liver mitochondria is capable of activating the AFBl into an 
electrophilic reactive form which then covalently modifies mitochondrial DNA, RNA and 
protein. The in vitro effect of AFBl on oxidative phosphorylation in rat liver 
mitochondria showed an inhibition of oxygen uptake by mitochondria (Ramachandra, 
1975). It has been shown that AFBl inhibits the electron transport chain between 
cytochrome band c. This uncoupling is thought to be due to a gross change in the 
structure of mitochondrial membrane or a binding of uncoupling agents at specific sites 
thus inhibiting oxidative phosphorylation (Ramachandra et al., 1975). In this study, 
mitochondrial membrane damage as indicated by swelling of mitochondria and the clearing 
of the mitochondrial matrix may be associated with both uncoupling and an inhibition of 
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oxidative phosphorylation in epoxide treated cells. Meldolesi et al. (1967) showed that 
there was a positive correlation between swollen mitochondria and low levels of ATP. It 
is widely accepted that there is a positive correlation between the metabolic activity of 
tissue and the number and size of mitochondria and the concentration of cristae. The 
paucity or absence of cristae in AFB l-8,9-epoxide treated cells shown in this study would 
suggest low metabolic activity. 
The alteration of the arrangement of cristae has been reported to be associated 
with a deficiency of cytochrome oxidase (Ghadially, 1982). Increased numbers of myelin 
figures observed in AFBl treated cells indicates increased mitochondrial turnover. This 
may be related to the toxic effects of AFBl. It is possible that since AFBl elicits its effects 
on the mitochondria, the cell responds by repairing the damage with an increased 
production of mitochondria. The presence of large vacuoles in epoxide treated cells is 
possibly the remnants of degenerate mitochondria. Previous studies have shown that the 
administration of toxin results in the covalent binding of AFBl to liver mitochondrial DNA 
at concentrations 3 to 4 times higher than nuclear DNA and is accompanied by the 
pronounced inhibition of messenger ribonucleic acid (mRNA) and protein synthetic 
activities (Niranjan and Avadhan, 1982). Backer and Weinstein (1980) showed that an 
epoxide derivative of benzopyrene similar to the AFB l-8,9-epoxide, modified 
mitochondrial DNA to a greater extent than nuclear DNA (more binding of the epoxide to 
mitochondrial DNA residues). Their work further showed that when cells were exposed 
to the AFBl-8,9-epoxide, the high uptake by mitochondrial membranes and the high lipid 
to DNA ratio of the mitochondria results in extensive modification of mitochondrial DNA 
by this carcinogen. This suggests that lipophillic carcinogens have a high affinity for 
mitochondrial membranes which may explain the altered mitochondrial morphology 
observed in AFBl and AFB l-8,9- epoxide treated cells. The presence of 5 to 10 nm gold 
probes in close proximity to and within the mitochondria is suggestive of the toxic effects 
elicited by the toxins resulting in altered mitochondrial architecture. The presence of toxin 
within the mitochondria suggests that it is one of the organe1les of attack. It is possible 
that the occurrence of CP 450 systems within the mitochondria is suggestive of its role in 
biotransformation of AFBl into the AFB l-8,9 epoxide. 
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In several models of experimental cell injury, changes in the ER have in fact been 
considered as constituting some of the earliest cytological changes (Trump et al., 1965). 
The swelling of the rough ER accompanied by degranulation in hepatocytes has been 
documented in previous studies where experimental animals were exposed to various 
noxious agents. Such alterations are known to hinder protein synthesis. AFB1 is known 
to inhibit protein synthesis, in a variety of ways, including the inhibition of RNA synthesis. 
The swelling of the ER may be linked to the storage of secretory products and/or the 
ingress of water due to an enzyme or mechanical defect in the rER (Ghadially, 1982). In 
this investigation, the most striking alteration in the rER was the decrease in the number of 
elongated profiles and a preponderance of short strands, distorted profiles, vesiculation or 
enlargement of the cisternae in both AFB1 and AFB l -8,9- epoxide treated cells. Another 
prominent feature was the presence of areas along the cisternae in which the membrane 
had been completely devoid of ribosomes. It has been shown that AFB1 derivatives 
directly effect the functional activity of polysomes (collection of ribosomes) (Sarasin and 
Moule', 1973). From the results obtained it is evident that the AFB l -8,9- epoxide treated 
cells showed more severely altered rER as compared to that of the AFB1 treated cells. It 
is possible that since AFB1 requires biotransformation into its derivatives to inhibit protein 
synthesis it does not immediately display a severe toxic effect while the synthetic AFB 1-
8,9-epoxide has a pronounced effect on the ultrastructure of the rER negating its 
functioning in protein synthesis. It has been previously shown that the aflatoxin derived 
compounds inhibit in vitro amino acid incorporation by the polysomes, while AFB1 is 
completely inactive in vitro (Sarasin and Moule' , 1973). 
In both the AFB1 and AFB l -8,9-epoxide treated cells the presence of areas of 
cytoplasmic lysis may be a consequence of the disintegration of swollen ER, rupture of 
lysosomal membranes or the action of lysosomal enzymes on pockets of glycogen. In 
addition the occurrence of focal cytoplasmic lysis within cytoplasmic blebs in epoxide 
treated cells is suggestive of the more pronounced cytotoxic effects of this derivative. 
Increased numbers of secondary lysosomes were also observed in treated cells. It is 
possible that AFB1 and its epoxide are sequestered into the secondary lysosomes in an 
attempt to isolate and digest the toxins. 
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Both TEM and SEM showed the presence of numerous cytoplasmic blebs in toxin 
treated cells. Cytoplasmic blebbing on cell surfaces is an early reaction of many cells to 
injuries by cytotoxic compounds and is thought to occur as a result of micro filament 
disruption, prior to loss of cell viability (Eriksson et al. , 1989). Both AFBI and the 
AFB 1-8,9- epoxide presumably elicit blebs as a consequence of its disruption of metabolic 
processes necessary to maintain the integrity of micro filaments. It has been suggested 
that an inhibition of ATP production resulting in a lowering of the level of cellular ATP 
induces microfilament disruption (Eriksson et al. , 1989). It has been shown that the 
AFBI-8,9-epoxide has a pronounced effect on the mitochondria which would result in an 
inhibition of ATP production. This may explain the subsequent formation of blebs. The 
presence of AFBI and AFB I-8,9-epoxide within blebs was confirmed in this study by 
immunocytochemical localisation and SEM. 
From the results obtained it is clear that the nucleolus is one of the sites of action 
of AFBI and the AFB I-8,9- epoxide derivative. Irregular clumps of condensed chromatin, 
nucleolar segregation and nucleoli with an extensive fibrillar component have been 
observed in both AFBI and AFB I-8,9- epoxide treated cells. In a previous study it was 
shown that a decrease in nuclear RNA content, micro segregation of nulceolar and an 
inhibition of RNA polymerase activity are all early effects of aflatoxin in liver (Edwards, 
1971). It has been suggested that the inhibition of hepatocyte RNA polymerase activity 
following a dose of AFB I, is due to an inhibitory effect of the toxin or a metabolite on 
some component of the nuclear chromatin. Nucleolar segregation induced by this toxin 
was extensively reviewed by Simard (1968) who suggested that nucleolar segregation 
reflects DNA binding and the subsequent inhibition of DNA-dependent RNA synthesis 
because of a loss of template activity of DNA. 
AFB I treated cells showed the presence of peripheral chromatin which reflects an 
inhibition of protein synthesis. Epoxide treated cells displayed single or double distinctive 
fibrous centers which is also indicative of an inhibition of RNA synthesis (Ghadially, 
1982). The presence of nucleoli with enlarged fibrillar component, is reported to be 
characteristic of an inhibition of nucleolar RNA synthesis which is known to be a 
consequence of the inhibitory effect of AFBI on the synthesis of the 60S subunit of 
127 
ribosomes (Moule, 1971). Moule (1971) has suggested that AFBl impairs the normal 
molecular processing of 45S RNA which would produce 40S and 60S subunits. It has 
been postulated that 45S RNA is associated with the fibrils of the nucleolus and the 
pathway of RNA maturation is from the template to the fibrillar component and then to 
the granular component of the nucleolus (Pong and Wogan, 1970). 
AFB2 caused no significant alterations in the hepatocyte nuclear and nucleolar fine 
structure. It has been reported that AFB2 is at least 350 times less active as an inhibitor of 
RNA polymerase than AFBl within 3 hours of dosing and a slight micro segregation was 
reported in the liver cell nucleolus following a large dose (200mglkg) of AFB2 (Edwards, 
1971). Edwards (1971) showed that AFBl binds more strongly to DNA in the form of 
the 8,9 epoxide while AFB2 needs to be biotransformed into AFBl in order to exert any 
biological effect (Chapter 2). 
There is good correlation between ultrastructural pathology and localisation of 
AFB 1 in organelles. The presence of label in the nucleus may represent the binding of the 
highly reactive epoxide to DNA forming the DNA adducts. It is now well established that 
the formation of the AFBI-DNA adduct is implicated in tumour formation but the 
mechanism by which AFBl or its derivative is translocated into the nucleus is still unclear. 
However cytosolic receptors for lipophilic carcinogens such as AFBl have been shown in 
tumorous cells. Mainigi and Sorof (1977) showed that AFB 1 gives rise to relatively high 
levels of DNA adducts and a wide variety of protein adducts. They also postulated that 
AFBl translocates across the nuclear pore as a ligand -protein complex by binding to 
proteins destined for the nucleus (histones) thus increasing its uptake, activation (nuclear 
CP450) and the subsequent damage to DNA leading to an increased risk of developing 
cancer. The nucleus is clearly one of the target organs of these toxin treatments. This is 
also reflected in the CLSM results which shows that the nucleus with the nucleolus in 
particular is the target site for AFB 1. It (CSLM) also shows a progressive sequence of 
movements of the toxin from the primary site (nucleolus) after 4 hour exposure period to 
the rest of the cell after 24 hours at 12.5/lglml. 
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CONCLUSION 
TEM, SEM and ICC showed that both AFBl and the AFB l-8,9- epoxide induce 
cellular alterations which ultimately leads to cell death. However the severity of the 
cytotoxic effects was more pronounced in the synthetic AFB l-8,9-epoxide treated cells. 
The synthetic AFBl-8,9-epoxide was found to adversely alter the ultrastructural pathology 
of the mitochondria and nucleus. The cytotoxicity of the biotransformed AFBl into the 
highly reactive metabolite is confirmed in this study by its in vitro pathological effects on 
cellular ultrastructure. 
The use of CLSM in localising these mycotoxins based on their fluorescence is a 
novel idea, which is still in its preliminary stages. Further work on the other mycotoxins 
will be carried out. 
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Chapter 5 
A COMPARISON OF THE CYTOTOXIC EFFECTS OF Zea AND ITS 
EPOXIDE DERIVATIVE ON CELL MORPHOLOGY 
5.1 INTRODUCTION 
Zearalenone, despite its structural dissimilarities with oestrogen, induces effects 
consistent with those produced by excessive steroid as well as synthetic oestrogen i.e. 
anabolic and l!terotropic activities. It has been extensively documented that the mode of 
action of Zea involves the interaction with oestrogen receptors, translocation of receptor-
Zea complex to the nucleus, combination with chromatin receptors and selective RNA 
transcription leading to altered biochemical effects (Reddy and Hayes, 1989). Over three 
hundred derivatives of Zea have been synthesised, some commercially as anabolic agents 
to improve growth rates and feed efficiency. Zearanol is one of the synthetic compounds 
used commercially as an anabolic agent (Goodman et al., 1987). 
Many of the reports pertaining to these compounds have relied on the use of 
animal models to assess oestrogenicity, therefore raising the complication of possible 
species differences in their hormonal activity. It has been discovered that oestrogen 
receptors do exist in the cytosol of hepatocytes. This discovery has stimulated research 
attempting to define a possible role of oestrogen receptors in the pathogenesis of hepatic 
disorders. Recent experimental evidence has suggested that the liver is the target organ 
for sex hormones (Eagon et a!., 1991). The oestrogen may play a role in the regulation of 
liver regeneration in that there is a strong temporal relationship between the increase in 
hepatic DNA synthesis and the total oestrogen receptor content of the liver (Eagon et al.. 
1991). This would therefore imply that Zea would have an effect on the liver. 
A zea epoxide synthesised in our laboratory has been assessed for its possible role 
in the metabolism of Zea. As with the AFB I -8,9-epoxide which is highly reactive and 
unstable we have attempted for the first time to produce an epoxide similar to the AFB1-
8,9-epoxide to compare its possible oestrogenic properties with that of Zea (Chapter 3). 
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The purpose of this study was to investigate the possible oestrogenic activity of Zea and 
its epoxide derivative using HepG2 cells in culture. Transmission electron microscopy 
was employed to compare the ultrastructural effects of Zea and its derivative while 
immunocytochemistry was used in an attempt to localise the toxins in the cell. 
5.2 MA TERIALS AND METHODS 
5.2.1 Mycotoxin treatment 
Confluent flasks (25cm3) of HepG2 cells were exposed to Zea (l2/lg/ml)and its 
epoxide derivative (12/lg/ml) for 24 hours. Following this exposure period cells were 
processed for TEM and ICC (as in Chapter 4). The microscopic techniques employed are 
summarised below. 
5.2.2 Transmission electron microscopy & Immunocytochemistry 
All ICC consumables were purchased from Sigma. The primary antibody used was 
a polyclonal (rabbit anti-Zea ) (1: 100 dilution), while the secondary antibody was goat anti 
rabbit IgG conjugated to a 5 to 10nm gold probe. Sections were viewed using a Joel-JEM 
lOOS transmission electron microscope. 
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Table 14 A summary of the steps involved in TEM and ICC 
TEM ICC 
Materials Cells grown 10 25cm
3 Cells grown 10 25cm3 
culture flasks culture flasks 
Fixation 1.5% gluteraldehyde 1.5% gluteraldehyde 
Post fixation Osmium tetroxide -
Dehydration 70%, 90%, 100% alcohol 70%, 90%, 100% alcohol 
Resin embedding Araldite Araldite 
Ultramicrotomy Copper grids Nickel grids 
StainlProbe U ranyl acetate IgG gold 
/Lead citrate 
5.3 RESULTS 
5.3.1 Transmission electron microscopy 
Distinct cellular alterations were observed in both Zea and Zea-epoxide treated cells. 
Ultrastructural alterations observed are summarised in table 14. 
Table 15 A comparison of the ultrastructural alterations observed in Zea and Zea 
epoxide treated cells. 
Zearalenone Zearalenone epoxide 
Endoplasmic reticulum(ER) 
Numerous cisternae of rough ER (rER). Few cisternae of rER 
Slight swelling of rER Grossly swollen rER with a loss of 
ribosomes 
Mitochondria 
Few swollen mitochondria Few swollen mitochondria and occasional 
elongated forms 
Slight change in cristae orientation- Some Slight change in cristae orientation. 
with cristae orientated parallel to Few cristae lying parallel to longitudinal 
longitudinal axis of mitochondria axis of mitochondria 
Often enveloped by ER Often enveloped by ER 
Nucleus 
Single nucleus with regular nuclear Multiple nuclei with invaginating nuclear 
membranes membranes 
Microsegregation of nucleolus Absence of micro segregation 
Very few smalllysosomes Severallysosomes 
A few cytoplasmic blebs with lysis Numerous cytoplasmic blebs with focal 
areas of cytoplasmic lysis 
No cytoplasmic lysis Areas of cytoplasmic lysis 
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The organelles most greatly affected by Zea and its epoxide derivative were the 
ER, nucleus and mitochondria. The Zea treated cells showed numerous rER often 
enveloping the mitochondria (Fig 5.1). The zea-epoxide treated cells displayed few rER 
and grossly altered rER which were swollen and showed a loss of ribosomes (Fig 5.2) . 
Zea treated cells showed slightly swollen and vessiculated rER with many intact ER (Fig 
5.3). 
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Nuclear alterations in Zea treated cells were an abundance of euchromatin and the 
micro segregation of the nucleolus which contained prominent fibrous centres (Fig 5.4). 
Epoxide treated cells showed the presence of multilobed nuclei and an absence of fibrous 
centers in the nucleoli (Fig 5.5). 
In Zea treated cells mitochondria appeared normal with a slight disorientation of 
the cristae (Fig 5.6) while in epoxide treated cells mitochondria were elongated and 
showed a loss of cristae and membrane integrity ( Fig 5.7). Both Zea and Zea-epoxide 
treated cells showed very few cytoplasmic blebs. In the Zea epoxide reaction however, a 
number of secondary lysosomes were present (Fig 5.8). Areas of cytoplasmic lysis were 
also observed (Fig 5.9). 
5.3.2 Immunocytochemistry 
Electron ICC results showed Zea and Zea epoxide to be localised in the nucleus, 
cytoplasm and within altered organelles. The following table illustrates the intensity of 
label in the altered organelles. 
Table 16 Intensity of label in toxin treated cells 
Organelles Zearalenone Zearalenone-epoxide 
Nucleus ++ ++ 
Cytoplasm ++ ++ 
Swollen ER ++ ++ 
Cytoplasmic blebs + + 
Along cell membrane + + 
+ few gold probes 
++ several gold probes. 
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Gold labelled Zea and zea-epoxide was found on the nuclear membrane (Fig 5.10), in the 
nucleoplasm (Fig 5.10); in the nucleolus (Fig 5.11); in the swollen ER and in close 
proximity to it (Fig 5.12); through the nucleoplasm to the nucleolus (Fig 5.13); from the 
cytoplasm to the nucleus (Fig 5.14) and outside the cell, within cytoplasmic blebs (Fig 
5.15). 
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Fig 5.1 Electron micrograph of a Zea (12Ilglml) treated HepG2 cell showing the presence of numerous 
rough endoplasmic reticuli (rER), indicative of enhanced protein synthesis, often enveloping 
the mitochondria (M). The cell is sandwiched between the flask (Fl) and the resin (R). 
! 
I 
Fig 5.2 Electron micrograph of a Zea-epoxide (12llglml) treated cell showing grossly altered rER with a 
subsequent loss of ribosomes (r). There are also a few cytoplasmic blebs (Cb) accompanied with 
focal areas of cytoplasmic lysis (t ). 
Fig 5.3 Electron micrograph of a Zea treated cell showing slightly swollen and vesicu1ated (V) rER, 
together with ovoid mitochondria (M). Flask (FL). 
Fig 5.4 Electron micrograph of a Zea treated cell showing microsegregation of the nucleolus (N)and 
the presence of fibrous centers (Fc). Cytoplasmic blebs (Cb). 
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Fig 5.5 Electron micrograph of a Zea-epoxide treated cell exhibiting multi-lobed nuclei (N). Flask (Fl) 
Fig 5.6 Electron micrograph of a Zea treated cell showing normal mitochondria (M) with slight 
disorientation of cristae and vesiculated rER. 
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Fig 5.7 Electron micrograph of a Zea-epoxide treated cell showing elongation of mitochondria (M) and 
loss of membrane integrity. There are also secondary lysosomes (L) filled with proteinacious 
material. Flask (FI), Resin (R). 
Fig 5.8 Electron micrograph of Zea treated cells showing the presence of a few cytoplasmic blebs (Cb),a 
desmosome(D) ( tight junction between neighbouring cells ), and numerous ovoid mitochondria 
(M). 
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Fig 5.9 Electron micrograph of a Zea-epoxide treated cell showing the gross alteration of the cytoplasm 
into areas oflysis (Cl) and the subsequent formation of the cytoplasmic blebs (Cb). Flask (Fl), 
Resin (R). 
Fig 5.10 Immunocytochemical (ICC) electron micrograph of a Zea treated cell showing the presence of 
gold-labelled anti-Zea as lOom gold probes along the nuclear membrane (Nm) and within the 
nucleoplasm (Np). 
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Fig 5.11 Ice electron micrograph of a Zea treated cell showing the presence of label within the nucleolus 
(N). The label is circled . 
1001101 . , 
Fig 5.12 ICe electron micrograph of a Zea-epoxide treated cell showing the presence of label in the 
swollen Er and in close proximity to it. 
Fig 5.13 lee electron micrograph of a Zea-epoxide treated cell showing the presence oflabel in the 
nucleoplasm (Np) and within the nucleolus (N). 
Fig 5.14 lee electron micrograph of a Zea-epoxide treated cell showing the presence of label in the 
cytoplasm (C) and within the nucleoplasm (Np). 
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Fig 5.15 ICC electron micrograph of a Zea-epoxide treated cell showing the presence oflabel within 




There have been many reports of compounds that mimic oestrogenic steroids 
particularly 17~-oestradiol. These claims have been substantiated by studies of the 
hormonal effects of these compounds in well established animal or cell culture assays. A 
survey of literature on the topic of oestrogenic principles found in plants and fungi 
suggested a list of 15 naturally occurring nonsteroidal compounds which represent 
putative agonists for the oestrogen receptor (Miksicek, 1994). One of these compounds is 
Zea which was found to interact with human oestrogen receptors by competing with 17~­
oestradiol. 
TEM showed a variety of ultrastructural alterations which is in keeping with 
various documented results on the oestrogenic activity of Zea. The nucleus was found to 
be one of the organe1les most affected by both toxic treatments. The altered 
ultrastructure and the presence of abundant label in the nucleus would suggest a possible 
DNA adduct formation. The biological effect of oestrogens in target tissues depend on 
the presence of cytoplasmic receptors. The steroid-receptor complex translocates into the 
nucleus, binds to the DNA template and in turn stimulates cellular RNA and protein 
synthesis. The binding affinity of the receptor for oestrogenic molecules is extremely 
strong and specific. However nonsteroidal compounds like Zea bind to oestrogen 
receptors and exhibit either agonistic or antagonistic effects of oestrogenic function (Kiang 
et al., 1978). From the results obtained, Zea displays an agonistic feature by promoting 
cell growth. A limited number of genotoxicity assays have been conducted with Zea. It 
was found that Zea and its oestrogenic metabolites showed a positive DNA damaging 
effect in recombination tests with Bacillus subtilis (Leszkomicz et al., 1995). Its ability to 
cause DNA damage in both microbial and mammalian assays indicated that Zea is possibly 
weakly genotoxic. The epoxide derivative however displayed antagonistic effects of 
oestrogenic function by reducing cell growth. 
The micro segregation of the nucleolus in both toxin treated cells suggest that the 
toxins inhibit DNA-dependent RNA synthesis (Ghadially, 1982). However the toxic 
effects of the Zea derivative is much greater than that of Zea. It probably binds to DNA, 
inducing mutations that limits cell growth. However in order for Zea to form an adduct it 
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must be metabolised to electrophillic compounds. These electrophilic compounds are the 
reduced products, a and ~-zearalenol (Goodman et aI. , 1987), the reduction of which is 
catalysed by microsomal and cytoplasmic fractions which is normally housed in the ER and 
the mitochondria. 
The ER was also greatly affected by the toxic insults but the severity of the cellular 
alteration was greater in the epoxide treated group of cells. These cells showed various 
stages of swelling of the ER; ranging from slightly to grossly swollen. The increased 
swelling was associated with a loss of ribosomes. The disorganisation of the rER 
(dilatation, vesicu1ation and disaggregation of po1yribosomes) in epoxide treated cells 
would imply that it disturbs protein synthesis since the ER is the site of protein synthesis. 
The phenomenon of degranulation was observed in both toxin treated cells but was severe 
in the epoxide treated group. It has been suggested that degranulation is an early, 
relatively mild lesion (Ghadially, 1982). However in epoxide treated cells drastic 
alterations such as vesiculation and dissolution of membranes of the rER were 
pronounced. This would suggest that the epoxide is highly toxic altering the architecture 
of the ER and subsequently protein synthesis. The lea treated cells however displayed 
slight swelling which may be a consequence of lea or its more oestrogenic derivatives like 
zearalenol (Kiess1ing et ai., 1978) but induced the production of numerous rER which may 
be indicative of enhanced protein synthesis. From Chapter 3 it was found that there is a 
significant difference between the toxic effects of lea and its epoxide derivative with the 
latter being highly toxic at 12~glm1. The close association betweenrER and mitochondria 
is necessary for the provision of ATP by mitochondria to rER actively synthesising 
secretory products (enzymes in this case). 
The mitochondria were also affected following the toxic treatment. lea treated 
cells displayed numerous mitochondria which could imply enhanced ATP production 
required by the active cells. Epoxide treated cells however displayed mitochondrial 
elongation and more severe alterations such as a loss of membrane integrity, disorientation 
and dissolution of cristae. Ghadially (1982) has suggested that the presence of 
disintegrating cristae is an indication of a noxious effect on the mitochondrion. The 
disorientation of the cristae is related to a deficiency of cytochrome oxidase in the 
mitochondrion which is essential in the production of ATP (Ghadially, 1982). 
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Mitochondrial damage is reported to suppress ATP production which in turn leads to a 
failure of the ATP-dependent Na+ pump at the cell membrane, resulting in cellular 
compartments becoming flooded with water. Increased cellular alterations in the epoxide 
treated cells, therefore, may be attributed to insufficient ATP levels by defective 
mitochondria. 
5. 5 Conclusion 
It is clear that the synthetic epoxide derivative of Zea does not display any 
oestrogenic properties in the liver associated with enhanced protein synthesis but displayed 
antagonistic features of oestrogen function. It was shown to be a highly toxigenic 
compound severely altering the essential organelles required for cell survival. Zea on the 
other hand displayed very little toxic effects on the cells in culture. Instead it appeared to 
promote protein synthesis in these human hepatoma cells which is in accordance with 
documented results on other cell lines with high oestrogenic receptor content (Goodman 
et al., 1987). The Zea epoxide has not been isolated as a naturally occuring compound 
and it is unlikely, if it is a highly reactive and unstable compound. One can postulate that 
its inability to display oestrogenic properties may be attributed to a possible covalent 
linkage with the oestrogen receptors thus stabilising the compound. However the Zea-




To date, much progress has been made in elucidating the biochemical and molecular 
mechanisms that underlie aflatoxin carcinogenesis. A substantial wealth of in vitro 
biochemical data that underlie aflatoxin metabolism suggests that humans are sensitive to 
the carcinogenic effects of aflatoxin. Clearly, the use of in vitro models has provided us 
with a greater understanding of aflatoxins and their cytotoxic effects on living systems. 
The evidence that incriminates aflatoxins as human carcinogens includes: the 
production of liver cancer in laboratory animals in a dose dependent manner; the presence of 
this toxin in animal and human foodstuff; physical characteristics such as heat stability which 
suggests their presence in foods ready for digestion; their presence in areas of the world in 
which the incidence of liver cancer is high and finally correlative studies show a significant 
relationship (Linsell, 1979). The toxic properties of these toxins is also another important 
factor since a number of reports of acute toxicity in man, some of endemic proportions with 
high mortalities has come from Asia and Mrica. 
At present, the mechanism of AFBl hepatotoxicity is yet to be fully elucidated. 
Direct covalent binding between activated metabolism and cellular macromolecules such as 
DNA, RNA and proteins has been proposed as a major event in its hepatotoxicity. From the 
results obtained it can be concluded that the localisation of the mycotoxins in specific 
organelles such as the nucleus, endoplasmic reticulum and mitochondria is indicative of its 
sites of action and subsequent interference with cellular metabolism. The use of innovative 
techniques such as confocal laser scanning microscopy and immunocytochemistry to localise 
the toxins within the cell makes the results obtained reliable and valid. 
The use of cells in culture to assess the cytotoxicity of the mycotoxins and their 
epoxide derivatives proved very effective together with the use of the MTT assay. The 
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results obtained suggested that both parent toxins (AFBl and Zea) were less toxic than their 
epoxide derivatives. These results correlated with the microscopy analyses which showed 
the severity of cellular alterations in the epoxide treated groups of cells. TEM showed the 
nucleus, ER and mitochondria to be the most affected organelles which are important in 
ensuring the normal functioning of the cell. 
Zea has received little attention as compared to aflatoxins because of its speculative 
role in human disease. One cannot ignore the fact that it exists as a potential carcinogen and 
needs a more in-depth study of its biochemical mechanisms. This investigation forms the 
basis of future studies which includes the isolation of oestrogen receptors, characterisation 
of its binding to Zea and the subsequent biological effects, using in vitro assays. More 
investigations in vitro and in vivo are necessary to determine how Zea metabolism in 
different tissues leads to DNA adducts, the nature of modified bases and the nature of the 
compounds bound to DNA. 
One cannot lose sight of the root of the problem of mycotoxins. Clearly a preventive 
measure would be improved husbandry, improved methods in harvesting, drying and storage 
of crops in defined areas. Such measures are necessary to protect the food supply from 
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Table 17 The constituents of the cell media (adapted from the Biowhittaker: 
Biotechnology products catalogue and technical manual, 1993). 
Component EMEM (m2/I) HBSS (m2fl) Earle's salts (m2fl) 
Inorganic salts 
CaCh. 2H2O 186.00 186.00 265 .00 
KCI 400.00 400.00 400.00 
KH2P04 60.00 60.00 
MgS04.7H2O 200.00 200.00 200.00 
NaCI 8.000.00 8.000.00 6.800.00 
NaHC03 350.00 350.00 2.200.00 
Na2HP04.7H20 90.00 90.00 140.00 
Other components 
Glucose l.000.00 l.000.00 l.000.00 
















Choline Chloride l.00 








The routine procedure in cell maintainence in a culture environment 
At the beginning of each working session, hands were thoroughly washed and the laminar 
flow was swobbed down with a70% ethanol solution. Before anything was introduced 
into the laminar flow it was swobbed down with the ethanol solution. Flasks containing 
growing cells were examined using an inverted microscope (Zeiss) and the condition of 
the cells were noted. 
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